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ABSTRACT
NEIGHBORHOOD CANCERIZATION: NEW APPROACHES LINKING SOCIAL AND
BIOLOGICAL MECHANISMS OF CANCER

Shannon M. Lynch
Timothy Rebbeck

Novel multidisciplinary and multilevel approaches are required to link biologic and social
mechanisms with cancer. We propose a new biosocial concept, “neighborhood cancerization,”
which postulates that residents of the same geographically-defined regions can be exposed to
common unfavorable circumstances. These common neighborhood-level exposures can in turn
have biological consequences that may result in an increased risk of cancer. Just as common
“molecular signatures” can differentiate tumor types, “neighborhood signatures” can identify
neighborhoods at increased risk for cancers of similar etiologic origins. Under a shared chronic
stress hypothesis, we test the neighborhood cancerization theory by first determining the effect of
neighborhood circumstances on telomere length (TL), a cellular marker of oxidative stress often
implicated in cancer development at the population level. After addressing common
methodologic concerns often cited in TL studies, we tested neighborhood and TL associations in
a multi-racial, multi-center setting and in the context of individual-level stressors using quantile
regression. We then developed and conducted a neighborhood-wide association study (NWAS)
using all available U.S Census variables and the Pennsylvania State Cancer Registry in order to
empirically identify common neighborhood factors related to prostate cancer. Our novel NWAS
approach demonstrates how agnostic, high-dimensional data analyses can be used to identify
neighborhoods and people at risk for high grade/high stage, aggressive prostate cancer. Our
work has implications for health disparities research, and provides evidence to support the
neighborhood cancerization hypothesis.
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CHAPTER 1

SOCIO-BIOLOGIC CONCEPTS IN CANCER
The Complex, Multilevel Etiology of Cancer
Cancer is a disease of abnormal and dysregulated cell growth[1]. A combination of
genetic and environmental factors (e.g. cigarette smoking) can initiate cancer
development[2-4], suggesting that cancer is etiologically complex. Thus, cancer
research has evolved from focusing on single risk factors to studies of complex
interactions
between

Figure 1. Multilevel Conceptual
Frameworks in Cancer

State
Policy

social,

Neighbor
hood

behavioral,
Macro-Environment

molecular,
and

Hospital/
Org.

Family/
Social
Support

Individual

environmental

Exposures
Behaviors
Psychosocial factors

risk factors.
Multilevel

Biologic
Tissue

conceptual

Cell
Metabolome

frameworks
Proteome

have been
developed to

Somatic
Genome

Cancer Development

Inherited
Genome

address the
complex nature of cancer etiology and allow for the simultaneous assessment of the role
of two or more etiological agents within a hierarchical or nested structure [5, 6], [7],
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[8],[3, 4, 9-14](Appendix A). Multilevel models are generally characterized by 1) The
macro-environment (or “eco-level” [3, 4]); 2) the individual; and 3) biology (Figure 1).
Each of these levels is further characterized by sub-levels that define domains of
variables involved in cancer etiology or outcomes (Appendix A). This framework
supports two main hypotheses: 1) factors at the macro-environment and individual levels
can directly affect biological events and result in cancer; 2) factors may interact in a
hierarchal fashion, such that biologic-level effects are affected by behaviors or
exposures of the individual, and individual level effects are affected by the macroenvironment [15]. The ability to address these hypotheses is complex at each level of
analysis, and even more complex when crossing levels.
Methodologic challenges in the Multilevel Framework
The biologic level is described here as single biomarkers at the cellular sub-level that
have been implicated in cancer development at the population level. Some examples
include telomere length and other oxidative stress markers, like cortisol levels[16].
Regardless of biomarkers used for study, inconsistent results (i.e. statistical effects vs no
association) are often noted across biomarker studies[17]. Inconsistencies in biomarker
research might be due in part to differences among study populations(e.g., age, gender,
race, etc.), laboratory approaches(e.g., how blood and DNA is collected, extracted or
stored)[18], or statistical methods used [17]. These issues are of particular concern in
multicenter research settings where data collection and population demographics often
differ, but analyses are combined as if center data comes from a single study. While a
number of quality control checks are available to assess validity and reliability of
biomarkers prior to associations, there is little consistency in analysis and reporting
across study samples[16]. Standardized assessments of biomarker data are lacking, but
2

would likely improve the acceptability of biomarker findings and lead to a more
widespread use of biomarkers in the multilevel context.
Macro-environment is described here in terms of the neighborhood sub-level.
Neighborhoods can be defined as the area or place in which a person lives[5], although
technical definitions of exact neighborhood polygon boundaries are numerous.
Neighborhoods have certain characteristics such as degree of deterioration,
urbanization, poverty, educational attainment and percentage of low-income residents
that have been correlated with increasing disease rates, risk behaviors, and unfavorable
health outcomes [19-23]. Neighborhood effects have been implicated in cancer
development[24, 25], even after controlling for individual-level factors[26].
Current methodologic approaches in neighborhood research call for a priori selection
of neighborhood variables from publically available U.S. Census data or selfadministered questionnaires[5, 27]. The problem with this approach is that findings are
not easily replicated due to a lack of consistency in defining neighborhood variables and
geographic boundaries [27-29]. This has limited the causal inferences that can be made
about neighborhood and disease research[27-29] and has likely contributed to fewer
studies with a multilevel focus, particularly investigations centered on neighborhood and
biology (Appendix B). Animal studies have demonstrated that unfavorable neighborhood
exposures, including social isolation from peers, can influence biological parameters
related to apoptosis and inflammation[30]. However, few human observational studies
have investigated the effects of unfavorable neighborhood characteristics on biological
markers related to disease[31]. For example, one multilevel study investigated etiologic
effects of all three levels on a cancer outcome[32]; 5 studies investigated macroenvironmental effects (namely neighborhood effects) on biomarkers implicated in cancer
3

at the population level[31, 33-35](Appendix B). Thus, studies linking biologic and social
mechanisms in cancer are limited, despite wide-spread acceptance of these multilevel
frameworks.
Neighborhood Cancerization: Principles
Current multilevel approaches lack shared pathways and methodologies that can be
used to frame the relationship between biologic and macro-environmental factors[5].
Thus, the creation of joint socio-biologic concepts and novel methodologies could open
doors for more multidisciplinary cancer investigations. The concept of field cancerization
is a pathobiologic theory that was originally proposed to explain synchronous or
metachronous tumors of the oral

mucosa[36]. Field cancerization came to refer to the propensity of a field of tissue to
become malignant based on either pathological observations or molecular markers[37].
In theory, field cancerization occurs from simultaneous wide-spread, unfavorable
4

exposures acting on cells and tissues within organs and organ systems (such as the
effect of cigarette smoking on the lung), as well as the migration of “patches” of
molecularly altered cells into larger tissue fields or territories that become predisposed to
cancer development[37]. Common molecular signatures in pre-malignant cells and
primary, malignant tumors provide evidence of the cancer field effect since they can be
used to identify tumor types of similar etiologic origins(Figure 2). Molecular markers for
field cancerization have been related to epigenetic changes[38-40], tissue microenvironment[41, 42], and telomere function[43] across different tissue types(Figure 2).
Analogous to a field of tissue for which unfavorable exposures may lead to
carcinogenesis, residents of neighborhoods may experience common stressors that can
lead to unfavorable biological consequences including heightened cancer risks(Figure
2). Under the proposed “neighborhood cancerization” concept, we hypothesize that
residents of geographically-defined regions can be exposed to common unfavorable
circumstances. These common neighborhood-level exposures can in turn have
biological consequences that may result in an increased risk of cancer. Further, just as
common “molecular signatures” can differentiate tumor types, “neighborhood signatures”
can identify neighborhoods at increased risk for cancers of similar etiologic origins[44].
Thus, neighborhood cancerization concepts at the social level are parallel to field
cancerization concepts at the molecular level (Figure 2).
Further, “top-down and bottom-up” mechanisms linking neighborhood and field
cancerization processes under similar biologic pathways are possible, but likely
complex, involving multilevel approaches, as well as complicated systems
approaches[45] (i.e, approaches that incorporate positive and negative feedback loops
among multilevel variables, which is outside the scope of this dissertation). Here, we
5

operate under the hypothesis that unfavorable social and economic environments at the
neighborhood-level may act in concert with biological, behavioral or psychosocial
factors(i.e., depression[46] and perceived stress[47]) at the individual level [5] to cause
chronic stress[48, 49] . In turn, biological processes related to oxidative stress are
affected by neighborhood and individual-level exposures in a way that limits the body’s
ability to fight disease processes like cancer. Thus, chronic stress is related to constant
“wearing down” of the body that can affect biological processes, accelerate the rate of
decline in physiological functioning, and ultimately affect the body’s ability to fight
disease processes such as cancer [17, 50-54](Figure 2).

Dissertation Synopsis
To address the issues described above, this investigation focuses on linking biologic
mechanisms and social mechanisms (at the macro-level) in cancer by proposing a novel
socio-biologic neighborhood cancerization framework. This concept will be tested under
a biologic pathway common to both social and biologic sciences, chronic stress. The
chronic stress model postulates that constant exposure to unfavorable stressors at the
neighborhood level can lead to cellular oxidative stress at the biologic level and
ultimately cancer initiation and progression[5] [17, 50-54]. These hypotheses can be
tested by applying methodologic approaches from biology to social science and from
social science to biology. Shared socio-biologic concepts and methods can serve as a
common “language” across disciplines, which can encourage the facilitation of the
multicenter, multilevel investigations that are needed to address the complex,
multifactorial nature of cancer among individuals who will always be nested within a
variety of ambient neighborhood landscapes and risk environments. In directly changing
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these environments we may be able to profoundly influence the burden of cancer,
perhaps more so than medical care or direct attempts to modify lifestyle[55].
Each chapter of this dissertation addresses a methodologic challenge associated with
testing the neighborhood cancerization hypothesis. Chapter 2 focuses on common
methodologic concerns often cited in multicenter, biomarker studies. In Chapter 3, we
determine the effect of neighborhood circumstances on telomere length (TL), a biological
marker of oxidative stress often implicated in cancer development at the population
level. We test neighborhood and TL associations in a multi-racial, multi-center setting
and in the context of individual-level stressors by applying a social science method,
quantile regression, to a biologic outcome. Borrowing methodologies from genome-wide
association studies(GWAS), in Chapter 4, we develop and conduct a neighborhood-wide
association study (NWAS) using all available U.S Census variables and the
Pennsylvania State Cancer Registry in order to empirically identify common
neighborhood factors related to prostate cancer. We demonstrate that NWAS can be
used to identify common neighborhood signatures that relate to high grade/high stage
prostate cancer. The socio-biologic concepts and methods discussed in each chapter
have the potential to serve as a common language across disciplines. These concepts
and methods can encourage the facilitation of multicenter, multilevel investigations that
are needed to address the complex, multifactorial nature of cancer.
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Abstract
Background: Leukocyte telomere length (LTL) has been associated with age, selfreported race/ethnicity, gender, education, and psychosocial factors, including perceived
stress, and depression. However, inconsistencies in associations of LTL with disease
and other phenotypes exist across studies. Population characteristics, including
race/ethnicity, laboratory methods, and statistical approaches in LTL have not been
comprehensively studied and could explain inconsistent LTL associations.
Methods: LTL was measured using terminal restriction fragment assays in 1,510
participants from a multi-center study combining data from 3 centers with different
sample characteristics and DNA processing methods. The association between LTL
measures, psychosocial factors, and race/ethnicity was evaluated using linear
regression and generalized estimating equations, accounting for population
characteristics including age, gender, cancer status and center, as well as DNA
extraction, a type of laboratory method.
Results: After considering sources of potential bias and confounding in multicenter
data, longer LTL was associated with African American race (p-value=0.04) and
Hispanic ethnicity (p-value=0.02), and less than a high school education (p-value=0.04).
There was an inverse relationship between LTL and perceived stress (p<0.001) overall,
and between LTL and high school education among African Americans (p-value<0.001).
Conclusions: With proper evaluation and statistical adjustment for center and
laboratory effects, combining data from multiple centers is valid and may resolve some
inconsistencies in reporting of LTL associations. Biologic effects on LTL may differ
under certain psychosocial and racial/ethnic circumstances and could impact future
health disparity studies.
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Introduction
Telomere DNA consists of long stretches of (TTAGGG) repeat DNA located at the
ends of chromosomes[1] and are required for the replication and stability of
chromosomes[1]. These repeats naturally shorten with age in all replicating somatic
cells[2] due to the inability of the cell to copy the ends of DNA and maintain length over
time[3]. Beyond chronological age, telomeres can also shorten prematurely in response
to cellular oxidative stress[4, 5]. In normal cells, telomere shortening results in cell
senescence or apoptosis[6, 7]. Senescence and apoptosis can function as tumor
suppressor mechanisms but can also disrupt normal tissue microenvironments and
contribute to aging phenotypes[8-11]. Cells with critically short telomeres that escape
apoptosis or senescence [12], and continue to replicate, have unstable genomes and
are believed to mark a critical step on the pathway to malignant transformation[2, 13]
[14, 15] [4, 16].
Leukocyte telomere length (LTL) has emerged as a potential biomarker of aging,
cumulative oxidative stress, and disease, and represents a promising intermediate trait
linking chronic cellular stress with disease pathogenesis. Several psychological and
social conditions have been associated with both an increase in cellular oxidative
stress[5, 17] and subsequent LTL shortening[5, 18-21]. Depression[22], perceived
stress[23], and educational attainment[5] are associated with LTL attrition. However,
elucidating the complex relationship between psychosocial factors and LTL[24] has
been difficult, and inconsistent results have been reported in the literature [5].
While previous studies have demonstrated that membership in certain race/ethnic
groups may be associated with a range of socioeconomic and psychosocial factors that
could result in shorter LTL [25], namely educational level[5] and perceived stress[23],
reports on the effects of race/ethnicity on LTL especially are limited and inconsistent.
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Most association studies of LTL have been conducted in female and Non-Hispanic White
populations[4, 5]. Studies that include racial/ethnic minorities suggest that Non-Hispanic
Whites have shorter LTL compared to African Americans(16, 17) and Hispanics[4].
However, one study suggested that African Americans and Hispanics have shorter LTL
than Non-Hispanic Whites[25]. Given the implications for disease prevention, as well as
the potential insights into common mechanisms affecting cellular oxidative stress and
aging, it is important to better understand both the racial and psychosocial contexts in
which changes in telomere biology occur using more diverse samples.
Inconsistencies in telomere research might be due in part to differences among study
populations, laboratory approaches, or statistical methods used, sometimes across
multiple study sites [4]. Beyond older age and male gender, there is little consensus
about the population characteristics that are associated with shorter LTL[4]. The effects
of biosample source and laboratory methods on telomere length measurements have
been studied, but are still being realized[4, 5, 14, 15, 26]. Differences in cell types used
to measure telomere length (i.e. buccal, blood leukocyte, tissue), DNA extraction
methods[27], and type of telomere length assay used can affect the validity and reliability
of telomere length measurements [4, 5, 14, 15], and ultimately reported LTL
associations.
Statistical approaches employed in LTL studies are often chosen based on the
characteristics of available study populations and customary laboratory methods. Yet,
the type of telomere length assay selected could affect the reporting and statistical
analysis of LTL outcome variables. Terminal restriction fragment(TRF) assays, known
as the gold standard for measuring LTL[26, 28], measure (TTAGGG)n lengths directly by
analysis of Southern blots of restriction digests of genomic DNA with frequently-cutting
enzymes; telomere length is reported in terms of the average size of the undigested
telomere fragment (which lacks sites for palindrome-dependent restriction enzymes) in
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base pairs or kilobases(kb) for each leukocyte DNA sample. Quantitative polymerase
chain reaction (qPCR), a high-throughput technique often used in large, populationbased studies[4, 29, 30], outputs LTL in terms of T/S ratios. Here, a PCR-generated
signal that is dependent upon the total (TTAGGG)n content of the sample (T) is
compared to the PCR signal from a known gene present only once in the genome (S).
T/S ratios of experimental genomic DNA samples are then each compared with those of
a reference genomic DNA sample, determined under identical experimental conditions,
to arrive at a value describing the telomere content of each unknown sample, which is
assumed to correlate closely with the average telomere length from TRF (24,25).
Additionally, some studies account for the potential effects of population characteristics
on telomere length outcomes and convert T/S ratios or LTL kb into standardized Zscores that are adjusted for age and gender[31, 32]. These differences in reported
telomere length metrics (e.g. kb, ratios, or Z-scores) can make comparisons across
studies difficult, and the implications of using various data transformations and statistical
approaches on observed LTL associations has yet to be formally evaluated.
In this study, we use data from a multicenter, multi-racial/ethnic, cross-sectional study
designed to investigate the effect of psychosocial factors on cancer-related biomarkers.
The study sample includes centers that used different LTL laboratory methods and had
different population characteristics. The purpose of this analysis is two-fold. First, we
conduct a comprehensive investigation of the collective effect of laboratory procedures,
study participant characteristics, and statistical measures in order to better understand
telomere length associations and any potential inconsistencies in observed associations
across multiple study sites. Second, once these factors have been considered, we
evaluate the effect of race/ethnicity on the relationship between psychosocial factors and
telomere length.
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Methods
Prior to assessing our primary data, we undertook a review of multicenter association
studies of LTL in order to ascertain laboratory factors and statistical approaches
commonly used in this setting (Supplementary Data File and Supplementary Table 1 in
Appendix C). These approaches could serve as methodologic factors that could
contribute to inconsistencies in reported associations(4).
Study Sample. Our primary study sample was drawn from three centers: the
University of Pennsylvania (Penn), the Ohio State University (OSU), and the University
of Texas Medical Branch (UTMB). These centers were originally part of the larger
Centers for Population Health and Health Disparities[33] whose main disease focus was
on the study of cancer. All study participants were recruited between 2004 and 2012.
Each center had its own protocol for recruitment and data collection that has been
described previously [34-36], and inclusion/exclusion criteria for each study are listed in
Table 1. Study participants agreed to donate a blood sample to extract genomic DNA,
and they completed a standardized questionnaire at the time of study enrollment. Study
participants were followed-up for cancer status. Informed consent was received from all
participants, and study protocols were approved by the Institutional Review Boards of
each center.
Covariates. Variables common to all 3 centers included: gender(male/female), age
at enrollment (continuous); race/ethnicity(White/Non-Hispanic, African American/NonHispanic, and Hispanic), educational status (less than high school or less than 12 years
of schooling; high school education or 12 years of schooling/GED); >high school
education or >12 years of schooling), disease status (cancer; yes/no), as well as other
behavioral factors, including smoking status (ever/never). The psychosocial factors in
this study were defined by perceived stress and depression. To evaluate stress, we

16

used the validated perceived stress scale (PSS)[37, 38]. This is a 10-item global
measure of perceived stress where higher scores indicate greater perceived stress(total
score range: 1–40). Total PSS was normally distributed in this sample, and we
dichotomized this variable to compare high (above median) to low (below median)
stress[39, 40]. Questions from the validated Center for Epidemiological StudiesDepression (CES-D) scale[41] and the CES-D revised(R) scale[42] were used to
ascertain depressive symptoms. Both the CES-D and CES-DR are 20-item scales (total
score range: 0-60). Higher scores, particularly those above 16, suggest more
depressive symptoms[41]. The combined total scores from CES-D and CES-DR were
positively skewed; we dichotomized at the clinical cut-point of 16[41] to compare those
with higher and lower levels of depressive symptoms. PSS, CES-D, and CES-DR
scales have been validated in multiethnic studies [43, 44].
Laboratory Methods.
Tissue Source for DNA: Here, All centers followed the same standardized blood draw
protocol and used the same tissue source to extract DNA, peripheral blood leukocytes.
Twenty milliliters of blood were drawn from each subject by a trained phlebotomist.
Samples were centrifuged and buffy coats were stored at -70°C until DNA extraction and
telomere assay.
DNA Extraction: Genomic DNA was extracted from each center individually and
sent to the Wistar Institute for analysis of LTL. OSU and UTMB samples were
processed using the QIAamp DNA Extraction Kit (Valencia, CA). Penn DNA samples
were extracted using Chemagen Magnetic Bead technology (n=61) and phenolchloroform extraction (n=40).
Terminal Restriction Fragment (TRF) assay: TRF length assays were used to
measure LTL from extracted DNA on all study samples (using duplicate samples), as
described previously by Kimura et al[45] and detailed in Supplementary Laboratory
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Methods(Appendix C). Briefly, genomic DNA samples were digested with restriction
enzymes Hinf I (10 U) and Rsa I (10 U; Roche), and mean LTL in kb was determined
using Telorun software[45].
Quantitative Telomere PCR (qPCR): For a subset of Cross-Center samples
(Penn, n=101 and OSU, n=111), LTL was also measured using the quantitative PCR
method developed by Cawthon, modified for compatibility with the Applied Biosystems
7900 HT instrument [30](Supplementary Laboratory Methods-Appendix C). Assays
were carried out in triplicate, and center samples were batch analyzed to minimize interassay variation. The T/S ratios of each experimental sample relative to the reference
sample were generated using the comparative CT (cycle threshold) method[30]. T/S
ratios and LTL kb were compared for quality control comparisons.
Coefficient of Variation Percentages (CV%): CV% were calculated for duplicate (
TRF measurements) or triplicate(qPCR measurements) samples using the pooled
standard deviation of the duplicates or triplicates divided by the overall mean of all
measurements. The TRF overall CV was 1.25%. The qPCR intra- and inter-plate CV%
were 4.9% and 12.9%, respectively.
Statistical Analysis. Data quality control measures were undertaken to identify any
potential measurement errors or inconsistencies. Box plots of LTL measurements were
generated to identify outlier points or data errors. LTL is described using means,
medians, standard deviations and ranges. The distributions of LTL were not normal, and
data transformations were conducted for statistical analysis. Methods used in past
multicenter studies were used to investigate inconsistencies and LTL associations
(Supplementary Methods/Supplementary Table 1-Appendix C). We evaluated
correlations between log-transformed LTL from TRF, and qPCR measurements overall,
by center, and by DNA extraction method[27]using[4, 26, 28-30] linear regression.
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Relevant study population characteristics overall and by center are summarized by
medians and frequencies. Comparisons of population characteristics across center and
by LTL were conducted using nonparametric tests (Kruskal-Wallis and Wilcoxon ranked
sum) for primary evaluations of population characteristics.
Associations between LTL and age and LTL and psychosocial factors were assessed
using the two common telomere length metrics reported in multicenter settings
(Supplementary Table 1-Appendix C), log-transformed telomere length(kb) and LTL Zscore. Inverse-weighted variance Z-scores were calculated by subtracting the logtransformed LTL sample mean from the original sample values and then divided by the
sample standard deviation[31, 32]. Z-scores were also adjusted for age, gender, and
cancer status by estimates within strata and then taking the weighted average across
strata[46-51] [52, 53]. Multivariable linear models were used to assess associations
with age and psychosocial factors that included relevant population and laboratory
factors. Relevant factors (identified from previous multicenter studies; Supplementary
Methods/Supplementary Table 1-Appendix C) were chosen for final inclusion in our
models using stepwise forward and backward variable selection approaches, with a
liberal variable inclusion cut-off of p<0.25. GEE models (using an independence
correlation structure and robust standard errors) [54]) were also fit in order to account
for correlation of observations within centers. Interactions between age, gender and
psychosocial factors were evaluated using appropriate cross-product terms within the
regression model. Subgroup analyses were further conducted by race/ethnicity and in
those without cancer and within the UTMB cohort. All P-values were two-sided. All
statistical analyses were conducted using STATA version 9.1.

Results

19

Laboratory Methods Evaluation. Applying proper quality control measures by
accounting for documented laboratory factors known to affect LTL measurements (i.e.
DNA extraction protocol, type of telomere assay, etc) ensures lab methods are not prone
to error that can subsequently affect LTL associations. In pilot experiments, we found
that TRF assay results consistently yielded excellent measurement CVs <2%, so these
assays were carried out on all samples. qPCR measurements for the OSU and UPenn
samples had higher CVs than the TRF assays(UPenn: qPCR 12.0 CV% and TRF 0.93
CV%; OSU: qPCR 0.12 CV% and TRF 0.01 CV%--consistent with the literature)[14],
whereas qPCR measurements of the UTMB samples yielded unacceptably high
measurement CVs (27 CV%), possibly due to an unknown analyte affecting the qPCR
reaction (24)), and were therefore excluded from the analysis. qPCR and TRF
comparisons were made with OSU and UPenn samples[14]. The relationship between
log-transformed TRF measures and T/S ratios for 211 samples with both TRF and T/S
ratio data showed an overall R2 of 0.60(Figure 1a). The R2 within centers was 0.71 for
Penn (Figure 1b) and 0.93 for OSU (Figure 1c). Comparing log-transformed TRF to T/S
ratios by DNA extraction method, the R2 for QiAmp DNA extraction was 0.81; for
Chemagen, 0.69 and for phenol-chloroform, 0.90. The mean (standard deviation) LTL
across all centers was 6.55kb (2.86). Within center, mean LTL was 8.42kb (4.50) for
Penn, 6.34kb (1.95) for OSU, and 6.42kb (2.71) for UTMB. Median LTL was significantly
different by extraction method (p-value<0.001)(Figure 1d). However, median LTLs were
not significantly different between Qiagen and Chemagen methods (p-value=0.48).
Study population evaluation. Baseline characteristics of the study overall (n=1510)
and by center were evaluated to determine potential clustering and confounding effects
by center (Table 2). The overall study population was 58.8% female. 15.7% had a
cancer diagnosis, and 51% had ever smoked cigarettes. The average age was 50.6
years, with a standard deviation of 15.6. All population characteristics, except for
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smoking, were significantly different across centers. Baseline study population
characteristics of the combined study population (includes all 3 centers) were compared
on median LTL and log-transformed LTL(kb) in order to compare our results to literature
and to identify factors related to LTL that could be tested in forward and backward
regression models with age and LTL(Table 3). Only cancer status had a significant
association with median LTL; cancer cases had longer LTL than those without cancer (pvalue=0.02). There was no statistical relationship between LTL and gender (median
LTL(kb), interquartile range (IQR): men=6.43, 4.14-8.39; women=6.33, 4.39-8.27; Table
3) in the overall cohort and when restricting the population to those without
cancer(median TRF(kb), IQR: men=6.01kb, 4.10-8.00; women=6.33, 4.48-8.27, pvalue=0.12; Supplementary Table 2-Appendix C).
Association of laboratory factors, population covariates, and LTL. There was no
correlation between age and log-transformed (R2= -0.08, p-value=0.45) and Z-score
LTL(R2= -0.10, p-value=0.49). The best fitting linear regression and GEE model for
continuous age and log-transformed LTL or Z-score were the same and included the
following: gender (GEE p-value<0.001), cancer status (GEE p-value<0.001), a gendercancer status interaction (GEE p-value<0.001), and DNA extraction method (GEE pvalue<0.001). The gender-cancer status interaction remained when using
OSU/UTMB(p-value=0.01) or UTMB data only(p-value=0.02).
Association of Race, Education, Psychosocial Factors and LTL. The distribution of
psychosocial factors differed significantly across centers (Table 2). The sample was
comprised of 45.6% non-Hispanic Whites, 45.0% Hispanics, and 9.4% African
Americans. The Penn and OSU study participants reported higher levels of education
than UTMB (p-value<0.001). OSU, which included only females, reported the highest
levels of stress and depression (p-value=0.03).

There were no statistically significant

associations between psychosocial factors and LTL (Table 3). However, African
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Americans had the longest median LTL (6.61kb, IQR=4.56-8.82), and Non-Hispanic
Whites the shortest (6.11kb, IQR=4.19-8.23). Patterns were consistent when restricting
the study population to those without cancer (Supplementary Table 2-Appendix C) and
UTMB only. No significant interactions between population characteristics and
psychosocial factors were observed.
Associations with log-transformed LTL and Z-scores with race and psychosocial
factors were estimated using both using linear regression (Model 1) and GEE models
(Model 2)(Table 4). Regardless of LTL measure or statistical model, there was a
significant, direct relationship between LTL and race/ ethnicity. For both LTL outcome
measures (log-transformed LTL and Z-score), GEE models presented a significant
relationship between lower levels of education (less than high school) (log-transformed
LTL p-value=0.02) and higher levels of perceived stress(log-transformed p-value<0.001).
Associations were similar when limiting the study population to those without cancer and
UTMB only (data not shown). Since both LTL measures resulted in similar association
results, and we thought it was important to account for cluster effects of center, the final
model was chosen to be a GEE models with log-transformed LTL .
No statistically significant associations between log-transformed LTL and
psychosocial factors were reported for Caucasians or Hispanics (Table 5). Compared to
those with more than a high school education, having only a high school education was
significantly related to shorter LTL (p-value<0.001) in African Americans.
Discussion
Inconsistent associations between LTL, race/ethnicity, and psychosocial factors in
literature have been reported [5] (16, 17) [23] [25], and few studies have evaluated the
association between LTL and psychosocial factors within race/ethnic subgroups[25].
Inconsistencies in literature between socioeconomic and psychosocial factors and LTL
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have been attributed to different laboratory and statistical approaches employed in these
telomere studies[4], but few studies have evaluated methodological effects. Multi-center
studies serve as an ideal opportunity for evaluating methodological effects on LTL
associations since they often combine data from centers with heterogenous populations
and varying laboratory approaches. Our findings suggest that combining and comparing
data from multiple centers is valid and can have little effect on LTL associations, with
proper adjustments. We first showed that our telomere measurements in the combined
study population were reliable and valid compared to other published studies[4, 5, 14,
15]. More specifically, we evaluated the source of DNA, type of telomere length assays,
CV percents, and DNA extraction techniques[4, 5, 14, 15] since they are known to
contribute to discrepancies in reporting associations between LTL and cancer and other
diseases[3, 14, 27]. Choice of tissue type and assay in our study were consistent with
literature(4), and correlations between TRF and T/S ratios for Penn and OSU were
within range of other studies (0.60-0.95)[26, 29, 30, 52, 53]. Although not included in
TRF and T/S ratio comparisons, UTMB LTL measures were reliable based on a 2.0%
TRF CV%[4].
Similar to published studies, phenol-chloroform DNA extraction resulted in longer
telomeres than Qiagen methods[14, 27], and Qiagen and Chemagen, both columnbased extraction methods, yielded similar median LTL results [14, 27]. The majority of
our samples were extracted using Qiagen and Chemagen(97.3%), thus our LTL
measurements could be underestimated and result in Type II error. However, the bias is
likely nondifferential. Few multicenter studies of LTL report and consider the effects of
DNA extraction on study outcomes(Supplementary Table 1-Appendix C), and DNA
extraction appears to contribute to inconsistent findings in telomere association
studies[14, 27].
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Age and male gender have been associated with shorter LTL(4) in many studies.
While we see the same trends in our data, we do not observe statistically significant
associations(Supplementary Table 2-Appendix C). Although the linear relationship
between age and LTL was weaker in the present study for log-transformed LTL(R2= 0.08) than previously reported(R2~0.15 [4]), the attenuated association observed
between age and LTL when adjusting for other covariates, like gender, is consistent with
other studies[53]. Additionally, the rate of telomere attrition may vary over lifespan, with
some studies suggesting more rapid attrition in younger ages (childhood) and in later
decades of life (over age 70) [55, 56]; the age range of the sample was 26-64 and the
median age of the sample was relatively young at 51 years (Table 2). We also found that
male cancer cases had longer telomeres compared to non-cancer cases ,and this has
been observed in literature[57], although inconsistently[58].
These initial evaluations informed which laboratory and population factors may affect
LTL associations in our study. DNA extraction methods, along with age, gender, cancer
status, and the interaction of gender and cancer status, were significant confounders.
Center-specific study recruitment led to specialized groupings of gender and cancer
status by center. Thus, center was a cluster variable, and GEE models, which
accounted for the within and between effects of the center cluster variable and include
stricter standard errors[59], appeared more appropriate in our analyses. Few multicenter association studies of LTL have accounted for potential cluster effects
(Supplementary Table 1-Appendix C). Concern over additional variability in LTL in those
w/ cancer and by center prompted us to compare findings when restricting the
population to those without cancer and UTMB only. We found that results were robust
and that extraneous variability in LTL appeared to be removed with adjustment for
relevant population and laboratory methods.
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We also evaluated the choice of outcome measure(log-transformed LTL or Z-score).
Most multicenter studies of LTL report log-transformed LTL (Supplementary Table 1Appendix C). However, Z-scores standardize telomeres based on sample distributions
and may be more appropriate in instances where the distribution of LTL greatly differs by
center or when confounders or model adjustment variables differ by center. Although
the magnitude of effects appear different (and often higher with Z-score), they are not
comparable. This is because the data transformation associated with each of these
measures lends itself to different interpretations. Nevertheless, patterns of association
between LTL and race/ethnicity and psychosocial factors were similar regardless of
which telomere outcome measure (log-transformed LTL or Z-score) was used.
To our knowledge, this is the first study to evaluate the effect of race/ethnicity on
the relationship between socioeconomic and psychosocial factors and LTL, and to more
comprehensively investigate the collective effect of laboratory procedures, study
population characteristics, and statistical measures on reported LTL associations. We
found significant associations between race/ethnicity, low levels of education, perceived
stress, and LTL. Associations between high levels of perceived stress and shorter LTL
have been reported[5]. We are only the second study to report that both African
Americans and Hispanics have longer LTLs than Non-Hispanic Whites[4]. Having less
than a high school education was associated with longer LTL, which is an association
not typically reported in literature(5)[25]. When stratifying the analysis by race, there
was a suggested association between longer LTL and less than a high school education
for Hispanics, and a significant association between shorter LTL and having a high
school education for African Americans. Thus, the racial, ethnic and educational
composition of our sample (including a large number of Hispanics with low education)
may have affected our education findings. Studies have found correlations with
socioeconomic status (SES) related to education and income, and race, namely lower
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SES conditions are associated with African Americans[60]. Being Hispanic is also
associated with lower levels of education in literature, as well as improved mortality rates
compared to African Americans[60], referred to as the Hispanic paradox[61-63]. Given
that shorter LTL is believed to be related to mortality[4], racial composition appears to be
an important consideration in LTL studies.
Our study had some limitations. This was a cross-sectional investigation, limiting us
to studying variables that were common to all 3 centers. For instance, duration and
severity of depression and perceived stress are more consistently associated with
shorter LTL[64], and LTL is likely to shorten over time(1). Stratified analyses by race
yielded small samples, particularly for African Americans, but findings suggest studies
focused on telomere biology by race/ethnicity are warranted. Like most LTL association
studies, differences in mean LTL could be influenced by the proportions of different kinds
of leukocytes[65]. The average LTL in any given study is considered to be a general
average of all the LTLs across all chromosomes and blood leukocytes. Although it is
unclear whether differential cell counts are affected by race/ethnicity in a way that would
explain the patterns we observed, one previous study found no association between
leukocyte type and LTL in African Americans or Non-Hispanic Whites[66].
The large multi-ethnic and multicenter composition of our study allowed for more in
depth analysis of the effects of laboratory and statistical approaches on telomere length
associations. Our study demonstrated that with proper evaluation and adjustment of
center and laboratory effects, combining data from multiple centers, with different
laboratory approaches and population characteristics, can be a powerful and valid
approach for assessing LTL associations. In addition, evaluating methodologic effects,
similar to what we have done here, within and across LTL studies may help resolve
inconsistent reports of LTL associations. Our data provide evidence of an association
between Hispanics and African Americans and longer LTLs, as well as potential
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relationships between educational level, perceived stress and LTL for certain
racial/ethnic sub-groups. Further study into the effects of socioeconomic and
psychosocial factors on LTL by race/ethnicity could have implications for research
involving health disparities and disease outcomes.

Table 1: Study Descriptions and Inclusion/Exclusion Criteria
Center

Original
Disease Focus:
Primary
Race/Gender

Sample
Inclusion criteria
size(n=1510)

Ohio State
University(OSU)[34]

Cervical cancer:
Non-Hispanic White/
underserved women

111

Women from Appalachia with
an intact uterine cervix and
corpus, not pregnant, and no
history of cervical cancer
recruited at time of routine
cervical cytology.

University of
Pennsylvania
Hospital System
(UPenn)[36]

Prostate cancer:
Non-Hispanic White
and AfricanAmerican/men

101

Male prostate cancer patients
from UPenn urology clinics with
blood sample.

University of Texas
Medical
Branch(UTMB)[35]

Stress effects near
oil refineries:
Non-Hispanic and
Hispanic Whites and
African
American/men and
women

1298

Population-based sample of
Non-Hispanic households and a
strata sample of Hispanic
households in Texas City, TX.
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Figure 1. a-c. Comparison of Log-transformed TRF to T/S Ratio overall and by center.
d. Median Telomere Length and R2 by DNA extraction method.
a. Overall

b. UPHS

c. OSU

d. DNA Extraction Method (Center,
N, Median, R2)
Chemagen
(UPHS, n=61, 6.80, R2=.69) QiAmP
(OSU/UTMB, n=1409, 6.28, R2=.81)
Phenol-Chloroform
(UPenn, n=40, 9.20,R2= 0.90)
* R2 ranges from 0.60-0.95 in
literature[26, 29, 30].
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Table 2. Study Characteristics

Population
Characteristics
Total Population (n)
Median Telomere
length (kb)a
Median Agea
Male Gender (%)
Cancer diagnosis(%)
Ever Cigarette
Smokers(%)
Race (%)
Non-Hispanic
White
African American
Hispanic
Education(%)
> High School
High School/GED
<High School
Psychosocial Factors
Median Total
Depression Score
Median Total
Perceived Stress

ALL Centers

UPenn

OSU

UTMB

pvalueb

1510
6.4 (4.3-8.3)

101
8.7 (4.2-11.8)

111
6.3 (5.1-7.9)

1298
6.3 (4.2-8.3)

0.0001

51 (38-63)
41.2
15.7
51.0

58 (53-63)
100
100
57.4

30 (26-43)
0
0
42.3

51 (38-64)
40.1
10.5
51.2

0.0001
0.0001
<0.001
0.08

45.6

89.0

98.2

37.8

9.4
45.0

11.0
0

1.8
0

9.9
52.3

<0.001

37.0
29.8
33.2

72.3
23.7
4.0

64.9
23.4
11.7

31.8
30.8
37.4

<0.001

6(1-15)

8 (3-13)

12 (7-22)

5 (0-14)

0.0001

19 (17-22)

20 (18-22)

22 (19-24)

19(16-22)

0.0001

*Abbreviations: University of Pennsylvania(UPenn), Ohio State University(OSU), University of
Texas Medical Branch(UTMB);
a
Medians(interquartile range for the median); b p-values comparing characteristics across each
of the 3 centers using Kruskal Wallis Test or Fisher’s Exact Test.
b
Range from low to high for Depression (0-60) and Perceived Stress Scale (0-40).
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Table 3. Unadjusted Median Telomere Length(kb) and Mean Log-Telomere Length(TL
in kb) by Study Characteristics(ALL n=1510)

Population
Characteristics
Age
Younger
age(<=51)
Older age(>51)
Gender
Female
Male
Cancer diagnosis
Yes
No
Ever Smoker
Yes
No
Race
Non-Hispanic
White
African
American
Hispanic
Education
> High School
High
School/GED
<High School
Psychosocial
Factors
Total Perceived
Stress
High Stress
(>19)

Median TL (kb)
(Interquartile
Range)a

pMean
b
value logTL(SD)

6.39(4.33-8.29)

1.78(0.44)

6.30(4.20-8.32)
6.33 (4.398.27)
6.43 (4.148.39)
7.14 (4.009.18)
6.28 (4.308.17)
6.45(4.25-8.29)
6.28(4.31-8.31)

0.68

1.77(0.50)

0.51

1.77(0.44)
0.58

1.78(0.51)

0.07

1.83(0.58)
0.02

1.77(0.45)

0.08

0.71

1.78(0.47)
1.77(0.48)

0.89

6.11(4.19-8.23)

1.75(0.490

6.61 (4.568.82)
6.42 (4.428.27)

1.83(0.48)
0.12

6.35(4.29-8.30)
6.13(4.29-8.30)
6.43(4.53-8.15)

pvaluec

1.79(0.45)

0.18

1.77(0.50)
1.76(0.48)
0.61

6.33(4.20-8.32)

1.80(0.43)

1.77(0.48)
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0.46

Low Stress
6.39(4.33-8.26) 0.60
1.78(0.47) 0.69
(<=19)
Total Depression
High
6.45(4.50-8.52)
1.81(0.44)
Depression (>16)
Low Depression 6.33(4.24-8.23) 0.12
1.76(0.48) 0.19
(<=16)
* Ranges of Median and Mean telomere length are similar to those reported in literature[26, 29,
30].
a
Medians(interquartile range for the median); b p-values comparing characteristics across 3 or
more groups using Kruskal Wallis Test, otherwise used Wilcoxon Ranked Sum Test; c p-values
comparing characteristics across 3 or more groups using ANOVA, otherwise used T-test.
Table 4. Adjusted Regression Estimates(Standard Errors) of Individual Race/Ethnicity,
Education, Psychosocial Factors and Log-Transformed and Z-Score Telomere
Length(TL in kb).
Log-Transformed TL
Model 1
Model 2

Model 1

Z-Score TL
Model 2

Race (compared
to Non-Hispanic
Whites)
African0.10(0.04)** 0.09(0.04)**
0.19(0.09)** 0.17(0.08)**
American
Hispanic
0.07(0.03)** 0.06(0.01)*** 0.16(0.06)** 0.13(0.03)***
Education
(compared to >
High School)
High School
0.01(0.03)
0.01(0.03)
0.01(0.06)
0.0004(0.04)
education
Less than
0.06(0.03)* 0.06(0.02)**
0.13(0.06)* 0.12(0.04)**
high school
Perceived Stress
High
-0.02(0.02)
-0.05(0.05)
Stress(compared
0.02(0.003)***
0.05(0.003)***
to low stress)
Depression
High
0.04(0.03)
0.04(0.02)*
0.07(0.06)
0.07(0.05)*
Depression
(compared to
low)
Model 1=Linear Regression; Model 2=GEE, accounts for clustering of center. LogTL model
adjusted by age, gender, cancer status, DNA extraction, and the interaction of gender and
cancer status. Z-score adjusted by age, gender and cancer status and model adjusted by DNA
extraction.
***p-value < 0.001;**p-value >0.001 and <0.05; *suggestion of significance p-value<0.15, but
>0.05.
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Table 5. GEE Estimates(Standard Errors) of Individual Socioeconomic and
Psychosocial Factors and Log-Transformed Telomere Length(TL in kb) stratified by
Race/Ethnicity and adjusted for age, gender, cancer status, gender-cancer status
interaction, and DNA extraction method.

Education
High School education
Less than high school
Perceived Stress
High Stress
Depression
High Depression

Non-Hispanic
Whites (n=688)

African
Americans
(n=142)

Hispanicsa
(n=688)

0.03(0.04)
-0.02(0.05)

-0.11(0.03)***
0.01(0.02)

0.001(0.05)
0.07(0.04)*

0.02(0.03)

-0.001(0.01)

-0.05(0.04)*

0.09(0.05)

0.02(0.04)

-0.01(0.04)

a

Linear Regression Model is reported since all Hispanics come from only 1 center. This model is
adjusted by age, gender, cancer status and the interaction of gender and cancer status. ***pvalue < 0.001;**p-value >0.001 and <0.05; *suggestion of significance p-value<0.15, but >0.05.
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Abstract
Background: Analogous to “field cancerization” in pathobiology, “neighborhood
cancerization” describes how individuals within areas exposed to common unfavorable
circumstances can experience biological consequences that may result in cancer and
other diseases. Telomere length (TL) shortening has been associated with exposure to
individual-level and neighborhood-level stressors as well as cancer development, yet
these relationships are not well understood. This study examined the complex
association between neighborhood characteristics and TL to test the neighborhood
cancerization hypothesis.
Methods: We studied 1,488 individuals from 127 census tracts in three regions of the
US. TL was measured from peripheral blood using terminal restriction fragment(TRF)
assays. Multilevel linear models and quantile regression models were fitted adjusting for
individual-level characteristics including self-reported race, education, perceived stress
and depression. Neighborhood sociodemographic exposures included population
density, urban/residential crowding, residential stability/instability, and socioeconomic
status (SES).
Results: Neighborhood population density, urban/residential crowding, residential
stability/instability, and SES were not significantly associated with TL using standard
linear models. Quantile regression revealed significant inverse associations between
population density and urban crowding and the 5th (population density, p-value=0.03;
urban crowding p-value=0.002), 50th(both p-values <0.001) and 75th percentiles(both pvalues<0.001) of the TL distribution. Significant associations between residential
stability and TL were seen at the upper tails of the TL distribution (95th percentile-pvalue=0.006; 90th percentile-p-value=0.005).
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Conclusions: The relationship between neighborhood sociodemographic variables and
TL may be nonlinear, with only a portion of the TL distribution being associated with
neighborhood-level exposures. Common exposures identified across different
neighborhoods can exert biological effects. These results support the neighborhood
cancerization hypothesis.
Introduction
The concept of field cancerization was originally proposed over a half century ago to
explain synchronous or metachronous tumors of the oral mucosa[1]. Field cancerization
came to refer to the propensity of a field of tissue to become malignant based on either
pathological observations or molecular markers[2]. In theory, field cancerization occurs
from simultaneous wide-spread, unfavorable exposures acting on cells and tissues
within organs and organ systems (such as the effect of cigarette smoking on the lung),
as well as the migration of patches of molecularly altered cells into larger tissue fields or
territories that become predisposed to cancer development[2]. Common molecular
signatures in pre-malignant cells and primary, malignant tumors provide evidence of the
cancer field effect. The biological basis for field cancerization has been related to
epigenetic changes[3-5], tissue micro-environment[6, 7], and telomere function[8] across
different tissue types.
Analogous to a field of tissue for which unfavorable exposures may lead to
carcinogenesis, residents of neighborhoods may experience common experiences and
stressors that can lead to unfavorable biological consequences including heightened
cancer risks. Exposure to socioeconomically disadvantaged neighborhoods can lead to
poorer health outcomes and a greater chance of death[9, 10], even after controlling for
individual-level socioeconomic factors[11]. This suggests that changes to the
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neighborhoods themselves, and not necessarily the individuals within those
neighborhoods, may be an underutilized yet high-return approach to reducing the
population burden of disease outcomes like cancer[12].
Potential mechanisms for explaining this association are complex, but one of the
most relevant mechanisms relates to chronic stress[13, 14]. Chronic stress may result
from exposure to unfavorable social and economic environments at the neighborhoodlevel acting in concert with psychosocial factors at the individual-level [15] (i.e.,
depression[16] and perceived stress[17]) . Thus, chronic stress is related to constant
“wearing down” of the body that can affect biological processes, accelerate the rate of
decline in physiological functioning, and ultimately affect the body’s ability to fight
disease processes such as cancer [18-23].
The hypothesis that neighborhood-level characteristics can therefore influence an
individual’s biological state is supported by numerous multilevel (i.e., accounting for
individuals’ experiences within environments) conceptual frameworks[15]. For instance,
animal models demonstrate that unfavorable macro-level environmental exposures,
including social isolation from peers, influence stress-related biological parameters, such
as cellular apoptosis and inflammation[24]. Further, human observational studies have
shown that unfavorable neighborhood environmental characteristics can affect biological
markers related to disease[25]. Telomere length (TL) has emerged as a promising
intermediate biological marker along the pathway linking chronic stress and disease
pathogenesis. Furthermore, the telomere pathway has been studied as a common
molecular signature in field cancerization studies[8, 26], and has been shown to be
associated with many cancers on the population level[21].
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Telomeres consist of long stretches of (TTAGGG) repeat DNA located at the ends of
chromosomes and are designed to protect against DNA degradation[27]. Telomeres
naturally shorten with age in all replicating somatic cells [18, 28], but can also shorten
prematurely in response to cellular stress[22, 29]. Associations have been reported
between shorter blood leukocyte TL attrition and individual-level chronic stress resulting
from perceived stress, depression[22, 29], and difficult or stressful life circumstances,
like caring for a chronically ill child[26]. Evidence also shows an inverse relationship
between shorter LTL and neighborhood socioeconomic status(SES) [15, 25],
disadvantage[30, 31] and unfavorable social environment[25], even after adjustment for
individual-level factors known to affect telomere length[25] such as biomedical variables
(including cardiovascular disease risk factors), lifestyle variables (such as smoking, body
mass index, diet, and physical activity) or socioeconomic variables (related to education,
income, and employment)[25]. Beyond being a potential biomarker of chronic stress,
telomere length is also implicated as a biomarker of aging, cancer, and cardiovascular
diseases[18-22, 29]. Thus, understanding the relationship between neighborhood and
telomere length could have implications for a range of poor health outcomes [18, 19, 22,
29] [20, 21], and could support the “neighborhood cancerization” hypothesis.
The neighborhood cancerization hypothesis is analogous to the concept of field
cancerization in that it considers the biological basis for neighborhood-level effects
among groups of commonly exposed individuals from different neighborhoods. We
hypothesize that residents of a neighborhood who are (as a group) exposed to stressors
or certain neighborhood social or physical characteristics may experience increased
cancer risk or unfavorable outcomes via biological responses to these exposures. The
goal of this paper is to employ multiple analytic approaches to evaluate how
neighborhood-level factors influence telomere length in a diverse, multi-neighborhood
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sample, in order to support the hypothesis of neighborhood cancerization. Further,
neighborhood factors that are found to be associated with telomere length in this study
could be used to create common neighborhood stress signatures, under a shared
chronic stress pathway that is currently not well understood.
Methods
Study Population. The study sample included data collected at 3 centers:
University of Pennsylvania (Penn), the Ohio State University (OSU), and the University
of Texas Medical Branch (UTMB). These 3 centers were originally part of the larger
Centers for Population Health and Health Disparities (CPHHD) Initiative[32]. A previous
investigation showed that combining data from these 3 centers is a valid approach[33]
that increases variation in ethnicity, geography, and neighborhood circumstances. Study
participants were recruited between 2004 and 2012. Each center focused on an
underserved population from a different geographical area and included protocols for
recruitment and data collection that has been described previously[34-36]. Briefly, OSU
included Non-Hispanic, White women from rural Appalachia (65% with a high school
education or greater) who were not pregnant and without cervical cancer at the time of
enrollment[26]. Penn included mostly urban, Non-Hispanic White(89%) and African
American(11%) men who were highly educated (72% with greater than high school
education) prostate cancer patients from urology clinics within the Penn hospital
system[28], and UTMB included a population-based sample of non-Hispanic households
and a strata sample of Hispanic households(52% of the study population) in Texas City,
TX[27], where 32% of the population had greater than a high school education and 37%
had less than a high school education. This geographic and demographic variation
allows for comparisons analogous to those in field cancerization that compare molecular
alterations in tissue sites within and across organ systems within an individual patient.
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Study participants from all centers provided a blood sample, and they completed a
standardized questionnaire at the time of study enrollment. Study participants were
followed-up for cancer status. Informed consent was received from all participants, and
study protocols were approved by the Institutional Review Boards of each center.
Outcome variable. TL was measured from extracted DNA from blood samples.
OSU and UTMB samples were processed using the QIAamp DNA Extraction Kit
(Valencia, CA). UPHS DNA samples were extracted using Chemagen Magnetic Bead
technology (n=57) and phenol-chloroform extraction (n=36). Terminal restriction
fragment (TRF) or Southern Blot assays were used to measure TL from extracted DNA
on all samples (using duplicate samples), as described previously[37]. The overall
coefficient of variation (CV%) was 1.25%, where a CV less than 2% is expected[22, 29].
Mean TRF in kilobases (kb) was determined using Telorun software[37]. TL was
reported in kb units.
Neighborhood variables. Census data from the American Community Survey
(ACS) were obtained at the census tract level to ascertain sociodemographic
neighborhood variables (http://www2.census.gov/acs2009_5yr/summaryfile/). Thus
neighborhood is defined here by select census tract social and economic conditions.
Census variables were linked to geocoded study data by the Federal Information
Processing Standard (FIPS) code, which uniquely identifies states, counties, and census
tracts[38]. In order to ensure confidentiality, we obtained 5-years of census tract level
estimates from the ACS. We used ACS version 2005-2009 since 86% of the study
population was accrued between 2004 and 2009. Individuals from the same census
tract were assumed to have the same neighborhood characteristics. Our data included
127 unique neighborhood clusters (census tracts) in total. Penn had the most unique
number of clusters (n=92), followed by OSU (n=29) and UTMB (n=6).
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Variables extracted from the ACS database to represent sociodemographic
neighborhood environment were chosen based on literature [28], [39-43] and included
population density (overall population/total land area in square miles), urban crowding
(housing units/square mile), residential crowding (represented by percent households
that have more than one occupant per room), residential stability (percent living in the
same house as 1 of year ago) and residential instability (percent who moved their
residence within the same State as of 1 year ago). The following variables were used to
construct a neighborhood socioeconomic status index (NSES): education (percent of
adults over 25 with less than a high school education), employment (percent male
unemployment), poverty (percent of households with income below the poverty line,
percent of households receiving public assistance, percent of female-headed
households with children) and income (median household income) [43]. Briefly, these
six variables related to income, education, employment, and poverty were the best
representatives of socioeconomic status(SES) in a factor analysis(Cronbach’s
alpha=0.93)[43]. Each of the 6 variables were summed after being transformed (i.e.,
higher values corresponded to higher SES). This total score was then standardized to a
mean of zero and a standard deviation (sd) of one. Thus, an index score greater than
zero denotes a tract with SES above the sample average[43].
Individual-level Covariates. Variables common to all 3 centers and that were found
to relate to telomere length in a previous analysis[33] were included as covariates in
statistical models: gender (male/female), age at enrollment(continuous); race/ethnicity
(White/Non-Hispanic, African American/Non-Hispanic, and Hispanic), educational status
(<high school (or less than 12 years of schooling), a high school education (12 years of
schooling/GED), or >high school education(>12 years of schooling)), disease status
(cancer; yes/no), total perceived stress score dichotomized at the median[44, 45], as
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measured from the Perceived Stress Scale [46, 47] (total score range: 1–40); and
depression dichotomized at a clinical cutpoint of 16[40] [48, 49], as measured from
questions from Center for Epidemiological Studies-Depression (CES-D) scale[50] and
the CES-D revised(R) scale[51] (total score range: 0-60).
Statistical Analysis. The distributions of TL and neighborhood variables were
examined for non-normality and appropriate data transformations were conducted.
Natural log-transformed TL was used as the outcome variable for all analyses. For ease
of interpretation, continuous neighborhood variables (with the exception of the NSES
index) were scaled by dividing by their standard deviation[25]. We used linear mixed
effect models to account for the multilevel nature of the data. This model allowed
clustering of individuals within neighborhoods and centers to estimate associations
between neighborhood variables and TL before and after adjustment for covariates [25].
Quantile regression was also used to assess associations with neighborhood factors
within segments of the TL distribution, accounting for clustering by census tract and
confounding by center [52, 53]. Quantile regression coefficients at the 5th, 10th, 25th, 50th,
75th, 90th, and 95th TL percentiles were considered.

The coefficients at each TL

percentile are interpreted as the change in log-transformed TL, given each unit increase
in the neighborhood variable standard deviation. Interactions among covariates were
evaluated in stratified analysis and by taking the cross-product terms of each variable in
both multilevel linear regression and quantile regression models. Individual-level and
neighborhood-level covariates were assessed for multicollinearity before inclusion in
statistical models using correlation matrices[54]. Robust standard errors are reported
and all tests were two-sided. A p-value<0.05 was considered to be statistically
significant. All analyses were performed using Stata 12.1 (StataCorp LP, College
Station, TX)[55].
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Results
Baseline characteristics of the study sample are presented in Table 1.

Of the 1,488

participants, 58.8% were female, 15.7% had a cancer diagnosis, and the median age
was 51 years (interquartile range (IQR) 38-63). The sample was comprised of 45.6%
non-Hispanic Whites, 45.0% Hispanics, and 9.4% African Americans. The overall
sample reported mild levels of stress on the Perceived Stress Scale(median score=19;
IQR=17-22) and low levels of depressive symptoms(median score=6, IQR=1-15). The
study sample had a relatively low median neighborhood SES index overall(-0.11; IQR=0.68-0.48), though neighborhood SES was different by region (UPenn=0.80(IQR=0.381.11); OSU=-0.35(IQR=-0.61- -0.17); UTMB=-0.10, IQR=-0.68-0.48); data not shown).
We report a median population density (total population/total area of land use in square
miles) of 3857.3(IQR=1694-5101)). The U.S. reports a population density of 87.5,
Galveston, TX reports 1158.2, and Philadelphia county reports 11,379.4.

The median

percent of households considered to be crowded (i.e., greater than one occupant per
room) was 2.6% for the overall study population, which is lower than the national
average[56]. The median percent of the population still living in the same house as of 1
year was 86.7%, and the median percent of the population that moved within the same
state in the past year was 2.9%.
No statistically significant associations between any neighborhood factor and logtransformed TL in multilevel linear regression models. These findings did not change
when adjusting for covariates and psychosocial factors (Table 2). In quantile regression
models, significant associations were seen between log-transformed TL and population
density and urban crowding at lower tails of the TL distribution (the 5th, 50th, and 75th
percentiles), and between residential crowding and TL at the 50th percentile (pvalue=0.03) (Table 3). For both population density and urban crowding, magnitudes of
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effect were small, but twice as large at the 5th percentile(0.10 for population density; 0.11
for urban crowding) than the 75th percentile of the log-transformed TL distribution(0.05
for population density; 0.04 for urban crowding). For neighborhoods where residents
remained in the same house in the past year, there was a significant, positive
association between TL and residential stability at the highest levels of the TL
distribution (95th percentile-p-value=0.006; 90th percentile-p-value=0.005). For
neighborhoods where residents moved within the same state in the past year, there was
a significant, inverse relationship between TL and moving within the same state in the
past year at the 90th (p-value=0.02) and 95th percentiles (p<0.001).
Discussion
This is the second study in adults to evaluate the relationship between TL and
neighborhood, and the first to adjust associations by individual-level psychosocial
variables. We report that neighborhood sociodemographic stressors have a complex,
possibly non-linear relationship with TL, a biological marker used in the study of agerelated disease, cellular and psychosocial stress, and field cancerization [8, 26, 57, 58].
We found that unfavorable neighborhood characteristics, namely urban crowding and
population density, were significantly related to shorter TL. This finding is consistent
with reports that shorter TLs are associated with unfavorable neighborhood
characteristics [25, 30, 31]. Residential stability (remaining in the same house in the
past year) and instability (moving within the same state in the past year) were more
strongly associated with longer TL at the upper tail of the TL distribution. These findings
are consistent with hypotheses that longer TL is associated with more favorable
neighborhood circumstances and less chronic stress[30, 31] [25]. Low levels of
residential stability are likely to affect groups of individuals differently, depending on their
social position or cultural resources[59]. Both impoverished and flourishing
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neighborhoods can have a high level of residential stability, yet impoverished
neighborhoods often have poorer health[59]. When we adjusted quantile regression
models for neighborhood SES, associations of TL with urban crowding and residential
stability remained unchanged (data not shown). Further, these relationships persisted
even after adjustment for individual-level psychosocial stressors.
Our findings are similar to results from a previous study of neighborhood and TL in
adults, using different neighborhood variables and analytic approaches[25]. The
previous study investigated the relationship between TL and composite scores of
neighborhood SES (from Year 2000 U.S. Census variables) and self-reported,
neighborhood social stressors (e.g., social cohesion, aesthetics, and safety)[25]. This
study modeled mean TL so that associations at the upper and lower tails of the TL
distribution were not distinguished. Given that the lower tail of the TL distribution is of
particular interest in disease susceptibility, we examined the association between
telomere length and neighborhood SES and socio-demographic environment using
quantile regression, an approach that could provide additional insights into neighborhood
associations given its focus on the extremes of the telomere length distribution[52, 53].
We examined associations using a composite score of neighborhood SES and
neighborhood variables from the U.S. Census related to population density, urban and
residential crowding and stability. We chose these variables to represent the
sociodemographic stressors because they provide insight into the social norms of a
neighborhood, as well as general insights into the neighborhood physical landscape[59,
60]. Additionally, these variables have shown associations with psychosocial stress[59,
60] and premature death[61] and have been considered surrogates for self-reported
measures of neighborhood stress investigated in previous TL studies[25]. More
specifically, urban and residential crowding are related to increases in social stress[61,
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62], can negatively affect family and social relationships[63], and impact social
cohesion[59, 60, 62]. Residential stability is related to neighborhood safety (i.e., safer
neighborhoods are related to increases in residential stability)[64], and residential
stability can affect social cohesion[59, 60]. This is because when a number of wellestablished residents or families leave a neighborhood, there can be a destabilization of
social norms and a disruption of social networks[59, 60]. Thus, our findings show that
while U.S. Census variables are generally considered less specific measures of
neighborhood phenomena than self-report data, they are readily accessible, reasonable
measures of numerous social and environmental phenomena, and can be used to
identify potential biologic effects of neighborhood environment and justify more in-depth
neighborhood investigations.
Our findings also suggest that when considering the relationship between complex
exposures such as neighborhood characteristics and biological variables such as TL,
novel statistical modeling tools may be required to obtain relevant insights into the
relationship between neighborhood factors and TL. While no statistically significant
associations were observed using multilevel, linear regression models, relatively
constant associations were observed between shorter TL and population density and
urban crowding using quantile regression. Quantile regression allows for the study of
predictors across the entire TL distribution, without having to categorize a continuous
outcome variable (with concomitant reduction in statistical power), and is better able to
evaluate effects at the extremes of a distribution [65]. Our results are consistent with
reports that shorter TLs are associated with increases in urban crowding or population
density [25, 30, 31]. Our findings demonstrate that using an approach like quantile
regression may identify associations that are otherwise missed by modeling simple
linear relationships or focusing on the mean of an outcome.
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Our analysis supports the concept of neighborhood cancerization. Unfavorable
neighborhood circumstances were related to TL, a biomarker indicated in disease
development[66], assuming a chronic stress pathway model that extends from macroenvironment (neighborhood) exposures to effects occurring at the cellular level[15]. Like
field cancerization, the present analysis identified potential common neighborhood
characteristics or signatures across different neighborhoods that were associated with
biological changes that have been implicated in carcinogenesis[2]. Longitudinal followup of TL and changes in residential stability, neighborhood gentrification, and in-out
migration of neighborhood residents and families over time could shed light into our
findings[59] and could provide further evidence of the neighborhood cancerization
effect[67].
More recently, field cancerization theory has been extended to include etiologic field
effects that focus not just on complex molecular changes and interactions within a cell,
but interactions of the whole host organism with external stimuli, a concept known as the
interactome[67]. The interactome includes gene-environment interaction studies[67],
although these studies have been almost entirely limited to traditional, often geoatmospheric measures of environment and much less so the social and population
measures of neighborhood environments used here. The neighborhood cancerization
effect proposed here extends the etiologic field effect hypothesis and provides some
insights into potential gene-neighborhood interactions. Although this has not been
tested, it is possible that individuals at the lower tails of the TL distribution in this
study(for instance, the 5th and 10th percentiles) could be genetically predisposed to
having shorter TL, and those in the upper tails of the TL distribution (the 90th and 95th
percentiles) could be genetically predisposed to having longer TL. Thus, based on our
findings, neighborhood effects related to residential stability may only be relevant in
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those who have inherently longer TL. This suggests that studying the relationship
between gene-neighborhood interactions, in the context of other relevant individual and
neighborhood-level social factors, is warranted and supports the etiologic field effect
concept[67].
Our study had some limitations. This was a cross-sectional study in three U.S.
regions, each with its own ascertainment strategy, and it is not a nationally
representative sample. This sampling strategy could affect generalizability of results.
However, we included data from multiple geographic regions, ethnicities, and disease
states to include maximal variation of factors that may influence TL. There is not a
standard, agreed upon approach to defining neighborhoods, and while the utility of predefined boundaries to define neighborhoods, such as census tract, has been
questioned, it is a commonly used approach and has the benefit of allowing for
standardized assessments of neighborhoods with readily available data[68, 69]. Future
studies could consider so-called boundary-free geographic methods to measure
environments that are more complex yet are an improvement upon more commonly
polygon-based methods[70]. Despite these few limitations, our findings were similar to a
population-based study with a comparable demographic composition[25].
Our findings demonstrate that neighborhood factors exert effects on biology, even
after adjustment for psychosocial stressors at the individual-level. The results of this
study provide evidence to support the hypotheses that neighborhood circumstances can
have biologic consequences, under a concept termed, neighborhood cancerization. TL
may therefore be a biomarker of the biological influences of neighborhood
circumstances on human health and disease. We conclude that neighborhood-level
factors may contribute to TL, chronic stress and disease development[40, 71], but that
the relationship of neighborhood on TL is complex.
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Table 1. Study Characteristics including neighborhood and individual-level psychosocial factors.
Population Characteristics
Total Population (n)
1488
Median Telomere length (kb)a
6.4 (4.3-8.3)
Median Agea
51 (38-63)
Male Gender (%)
41.2
Cancer diagnosis(%)
15.7
Race (%)
Non-Hispanic White
45.6
African American
9.4
Hispanic
45.0
Education(%)
> High School
37.0
High School/GED
29.8
<High School
33.2
Median Total Perceived Stressb
19 (17-22)
Median Depressive Symptomsb
6(1-15)
Neighborhood Factors
Median Neighborhood SES Index
-0.11(-0.68-0.48)
Median Population Density (total population/sq.
3857.3(1694-5101)
mile)
Median Urban Crowding (housing units/sq. mile)
1755.8(695-1833)
Residential Crowding (%)
Median % households that ARE crowded
2.6 (0.6-11)
Residential Stability(%)
Median % living in the same house as 1 year
86.7(78-91)
ago
Median % moved within the same state(not
2.9 (1.2-2.9)
county)
a Medians(interquartile range for the median);
b Range from low to high for Depression (0-60) and Perceived Stress Scale (0-40)
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Table 2. Estimates and standard errors(SE) for associations between log-transformed telomere
length (kb) and neighborhood factors(scaled by standard deviation(SD), before and after
adjustment for covariates (n=1488).

Increasing Neighborhood
SES Index
Increasing Population
Density (sq. meters)
Increasing Urban
Crowding (housing units/sq.
mile)
Increasing Residential
Crowding
% Crowded households
Increasing Residential
Stability(%)
%Same house in past
year
Increasing Residential
Instability (%)
%Moved within same
state in past yr

Neighborhood Factors scaled by SD
Model 1
p-value Model 2
p-value
(Estimate, SE)
(Estimate, SE)
-0.01, 0.04
0.90
-0.01, 0.04
0.89
-0.02, 0.02

0.32

-0.03, 0.02

0.20

-0.02, 0.02

0.36

-0.02, 0.02

0.23

-0.05, 0.07

0.52

-0.05, 0.08

0.48

0.06, 0.05

0.18

0.05, 0.05

0.23

-0.01, 0.04

0.89

-0.001, 0.04

0.98

Model 1 is the crude analysis without covariates. Model 2 includes adjustment for age, gender,
cancer status, race/ethnicity, perceived stress(high/low), depression(high/low), education level,
and the interactions of gender and cancer status, and race/ethnicity and educational level.
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Table 3. Associations with Neighborhood factors (standard deviation adjusted) across the logtransformed telomere length distribution(kb).

Neighborhood
Factor
Increasing
Neighborhood
SES
Increasing
Population
Density
(population/sq.
mile)
Increasing
Urban
Crowding
(units/sq. mile)
Increasing
Residential
Crowding
% crowded
households
Increasing
Residential
Stability(%)
% in the same
house in past
year
Increasing
Residential
Instability(%)
% Moved
within same
state in past yr

Log-Transformed Telomere Length Distribution
10th
50th
75th
90th
Percentile
Percentile
Percentile
Percentile
Coeff(SE)
Coeff(SE)
Coeff(SE)
Coeff(SE)
p-value
p-value
p-value
p-value

95th
Percentile
Coeff(SE)
p-value

0.003(0.02)
0.86

0.01(0.03)
0.58

-0.004(0.03)
0.85

0.01(0.02)
0.71

0.01(0.03)
0.72

-0.10(0.05)
0.03*

-0.07(0.04)
0.11

-0.05(0.01)
<0.001*

-0.05(0.01)
<0.001*

-0.11(0.03)
0.002*

-0.08(0.03)
0.02*

-0.04(0.01)
<0.001*

-0.05(0.01)
<0.001*

0.04(0.04)
0.28

-0.02(0.02)
0.45

-0.01(0.02)
0.70

-0.02(0.01)
0.27

0.001(0.001)
0.03*

-0.01(0.02)
0.78

0.03(0.03)
0.28

0.002(0.001)
0.09

0.03(0.04)
0.56

0.02(0.04)
0.64

0.03(0.03)
0.27

0.04(0.02)
0.12

0.04(0.02)
0.005*

0.04(0.01)
0.006*

0.03(0.03)
0.32

0.03(0.02)
0.19

-0.01(0.01)
0.70

-0.01(0.01)
0.25

0.03(0.01)
0.02*

-0.03(0.01)
<0.001*

5th
Percentile
Coeff(SE)
p-value

0.02(0.03)
0.51
0.05(0.04)
0.27

-0.01(0.02)
0.74

Model includes adjustment for age, gender, cancer status, race/ethnicity, perceived
stress(high/low), depression(high/low), center, educational level, and the interactions of gender
and cancer status, and race/ethnicity and educational level.
*p-value less than 0.05
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Abstract
Background: Cancer is accepted to be the result of complex interactions of multiple
variables measured at biological, individual and neighborhood environmental levels.
However, systematic approaches to assess neighborhood-level effects are limited. We
propose a Neighborhood-Wide Association Study (NWAS), a systematic approach
analogous to a genome-wide association study (GWAS), in order to identify
neighborhood-level signatures associated with aggressive prostate cancer.
Methods: We empirically evaluated the association between all Year 2000 U.S. Census
variables and prostate cancer aggressiveness among White prostate cancer cases
reported to the Pennsylvania State Cancer Registry using a multi-phase approach that
accounted for age, year of diagnosis, spatial effects, and multiple comparisons. The
outcome of interest was aggressive (Stage>3 and Gleason grade >7) vs. non-aggressive
(Stage<3 or Gleason grade<7) cancer. Using generalized estimating equations (Phase
1) and Bayesian statistics (Phase 2), we calculated odds ratios (OR) and credible
intervals (CI). In Phase 3, principal components analysis was used to account for
correlation among variables.
Results: From 14,663 census variables, we identified the top 17 variables associated
with prostate cancer aggressiveness. The top two hits related to transportation
(OR=1.05; CI=1.001-1.09) and poverty (OR=1.07; CI=1.01-1.12). Our findings also
confirm previous associations between poverty, income, housing, employment,
immigration, and cancer.
Discussion: This NWAS methodology addresses gaps in neighborhood research by
introducing a standardized evaluation of a myriad of complex neighborhood factors on a
disease outcome. This approach has implications for health disparities research, and
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provides a foundation for multidisciplinary, multilevel research by proposing a common
methodological framework for identifying relevant neighborhood variables.

Introduction
Numerous conceptual frameworks suggest that cancer results from a complex
interaction of factors at the macro-environmental (e.g. neighborhood), individual, and
biologic levels[1, 2]. However, novel approaches that could be used to evaluate the joint
effect of these multiple levels have not kept pace with other fields, in which highdimensional computing approaches have been used to discover etiologic agents. For
example, genome-wide association studies (GWAS) have driven population-based
cancer research in recent years [3-6]. GWAS studies use high-throughput, low cost
technology and readily available genome-mapping data to evaluate the role of millions of
genetic markers with a variety of diseases and traits using a unbiased, model-free
framework [7, 8].
Applying methods borrowed from GWAS, environmental-wide association studies
(EWAS) were subsequently developed to study the effect of exposures at the individual
level (e.g., pesticides, cigarette smoking, plastics, air pollution, etc.), and to provide
insight for subsequent gene-environment interaction studies[9]. However, EWAS
methods have not been applied to cancer outcomes, and the impact of social
environment, particularly at the neighborhood level has not been comprehensively
studied using this approach. Thus, borrowing concepts from GWAS and EWAS, we
propose a novel, empirical approach known as a neighborhood-wide association study
(NWAS) to evaluate the effect of multiple neighborhood-level environmental exposures
on disease etiology and outcomes. The overarching goal of this method is to
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systematically identify “neighborhood signatures” that may be related to disease
phenotypes.
In proposing this new method, we also borrow from the pathobiologic concept of field
cancerization, which refers to the propensity of a field of tissue to become malignant
based on either pathological observations or common molecular markers[10, 11].
Common molecular signatures that provide evidence of the cancer field effect include
changes in epigenetics[12-14], the tissue microenvironment[15, 16] and telomere
function[17]. In theory, field cancerization can occur from simultaneous, wide-spread,
and unfavorable exposures acting on cells and tissues within organs and organ systems
(such as the effect of cigarette smoking on the lung), as well as the migration of
“patches” of molecularly altered cells into larger tissue fields or territories that become
predisposed to cancer development[11].
Neighborhood circumstances and lived conditions also contribute to geospatial
effects on populations [18, 19]. Under the proposed “neighborhood cancerization”
concept, we hypothesize that residents of a neighborhood who are (as a group) exposed
to certain neighborhood characteristics may experience a similar biological or social
effect that may relate to their cancer risk as a group, and that common unfavorable
neighborhood circumstances identified across different neighborhoods can contribute to
tumors of similar etiologic origins[19].
Compared to other cancers, prostate cancer is disproportionally affected by social
circumstances. When compared to European American (EA) men, African American
(AA) men are more likely to receive differential treatments for prostate cancer, and are
twice as likely to die of prostate cancer[20]. This is the largest disparity seen in any
cancer site. Studies of neighborhood and prostate cancer show that neighborhoods with
poor socioeconomic (SES) circumstances, as measured by single, a priori selected U.S.
census variables and SES deprivation scores derived from combinations of US census
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variables, are related to high-grade prostate cancer[21-24]. These effects are apparent
independent of individual level exposures[25-28]. Thus, the study of neighborhood
effects on prostate cancer risk is warranted, particularly given that few prostate cancer
risk factors at the individual level have been identified [29].
We hypothesize that signatures of factors that influence disease risk and severity
may impact groups of residents in neighborhoods, and that these effects can be
efficiently identified by using an NWAS approach. In this paper, we introduce the NWAS
methodology, and demonstrate how agnostic, high-dimensional data analyses can be
used to identify neighborhoods at risk for high grade/high stage, aggressive prostate
cancer.
Methods
Study Population. Anonymized data from the Pennsylvania Department of Health
Prostate Cancer Registry was provided on prostate cancer patients diagnosed in the
Commonwealth of Pennsylvania from 1995 to 2005. Residential addresses of prostate
cancer patients were cleaned by trained research staff and geocoded at the census tract
level by using Arc GIS software. The registry included variables related to prostate
cancer diagnosis (tumor stage and grade), age at diagnosis, year of diagnosis, and
race/ethnicity. We focused only on Caucasian prostate cancer cases in this analysis
(n=80,575), and excluded those who had only a P.O. Box address (n=112), and those
missing tumor grade or stage (n=3371), age (n=2), or year of diagnosis (n=4). A total of
77,086 men were included in the final analysis (Appendix D Supplementary MethodsPhase 0 Data Cleaning).
Neighborhood Variables. All 24,634 census tract variables available in the 2000
U.S. Census Summary File 1 (SF1) and Summary File 3 (SF3) were downloaded from
Social Explorer (http://www.socialexplorer.com). Year 2000 U.S. Census data was used
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since it served as the midpoint for the prostate cancer registry data from 1995-2005.
Social explorer automatically calculates percentages, aggregates, and medians for each
variable in the U.S. Census tables. The SF1 form, referred to as the “100%” data, is
distributed to every household in the U.S. and asks questions about each person within
the housing unit related to demographic information, such as age, gender, and race, as
well as general housing questions related to occupancy, tenure, etc[30]. The SF3 form
is distributed to 5% of all people and housing units in the U.S and asks more specific
questions related to socioeconomic status and physical environment characteristics,
such as migration, language ability, disability, veterans status, vehicle availability,
kitchen and plumbing facilities, etc. [31] . Both SF1 and SF3 variables are used
frequently in social science investigations[24-27, 32-35]. All SF1 and SF3 variables
were evaluated for missingness (Appendix D Supplementary methods/ Appendices E
and F and Supplementary Digital Files 1-4). Variables with greater than 10%
missingness (n=8,092) and modal values that comprised over 95% of the data (n=1,879)
were excluded. After these exclusions, 14,663 census variables were included in the
analysis.
Data Join of Study Population and Neighborhood Variables. Microsoft Visual Studio
2008 was used to execute the join by importing both the census tract level cancer
registry and the SF1 and SF3 census data into a program where the geographic
identifier was set to the census tract FIPS code[30]. Individual prostate cancer cases
were linked to the neighborhood variable values of the census tract in which they live.
Thus, cases arising from the same census tract were assumed to have the same
neighborhood characteristics.
Outcome Definition. All incident, Caucasian prostate cancer cases occurring in PA
from 1995-2005 were included in this study. Incident prostate cancer cases were
identified according to ICD-0-3 site and morphology coding. We assumed complete
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case ascertainment, given that medical facilities are required by law to report all
diagnosed cases of prostate cancer in PA [36]. Tumor stage is said to measure
screening effects, whereas tumor grade is said to measure the biologic composition of
the tumor[37], thus we created a combined, “prostate cancer aggressiveness” variable
for our primary outcome[38, 39] that was defined by cases with a high tumor stage
(stage 3 or 4) and high tumor grade (grade 7+), compared to controls with other
combinations of these two variables[38, 39]. Tumor stage and grade were determined
by Surveillance, Epidemiology, and End Results (SEER) coding criteria for stage and
histology variables, respectively[40, 41]. Subjects with low stage prostate cancer (Stage
1 and 2) were defined by SEER Stages 0 and 1; subjects with high-stage (Stages 3 and
4) were defined by SEER Stages >2[38, 40]. Low tumor grade (Gleason score of 6 or
below) and high-grade (Gleason score of 7 or greater) prostate cancer was determined
from the SEER 6th digit coding for histology and differentiation[42]. Sixth digit diagnosis
codes that were equal to 6 or 9 were excluded because grade or differentiation could be
not determined, was not stated, or was not applicable[42]. Subjects who were missing
grade variables also were excluded from our outcome definition (n=3,371) (Appendix D:
Supplementary Methods-Phase 0). After these exclusions, we defined two comparison
groups for analysis: aggressive prostate cancer cases (n=6,416) and non-aggressive
prostate cancer cases (70,670). On average, there were 2 cases of aggressive prostate
cancer compared to 23 non-aggressive prostate cancer cases in each census tract.
Statistical Analysis. Data reduction techniques were applied across 3 analytical
phases to identify continuous neighborhood variables associated with aggressive
prostate cancer. Each phase included progressively more stringent statistical criteria, in
order to minimize false positive findings. All models were adjusted for age at diagnosis
and year of diagnosis.
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In Phase 1, we used Generalized Estimating Equations (GEE) with a logit link
function, binomial distributions, and robust standard error methods to estimate odds
ratios (OR) that describe the relationship between census variables and disease
aggressiveness[43]:
Logit(p)= α+β0xage+ β1xyear of diagnosis + β2xneighborhood variable (i, j) + Corr + Error; (Eq. 1),
where i= individual prostate cancer cases; j=census tracts and Corraccounts for clustering effects within an exchangeable correlation matrix

P-values were Bonferroni-corrected to an alpha of 0.05 to account for multiple
comparisons[44], thus Bonferroni-adjusted p-values less than 0.05 were significant in
this analysis. Phase 1 analyses were conducted using SAS 12.0 statistical software.
In Phase 2, we used spatial regression to further evaluate those variables that
reached statistical significance in Phase 1 and to account for and describe the spatial
variability in our data. We specified a Bayesian random effects model in which we allow
both global and local smoothing:
Logit(p)= α+β0xage+ β1xyear of diagnosis + β2xneighborhood variable (i, j) + V(j) + U(j)

(Eq. 2)

where i= individual prostate cancer cases; j=county and V(j) are independent non-spatial random effects and U(j) are spatial random

effects.

We model the spatial random effects using an intrinsic conditional auto-

regressive (ICAR) prior:
|
where
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is the set of neighbors of county j, mj is the number of neighbors,

mean of the spatial random effects of the neighbors, and

is the

is the conditional variance

whose magnitude determines the amount of spatial variation[45]. This model imposes
smoothing by assuming that the spatial effect in a particular county is similar to the mean
of the spatial effects in near-by counties, with the strength of the similarity determined by
the number of neighbors (counties with more neighbors will have stronger similarities
imposed). We define counties j and k to be neighbors if they share a common boundary.
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Under this model, we must assign distributions to
Gamma(0.05,0.001) prior distribution on

=

and
and on

. We specify a
=

. We conducted

sensitivity analyses using different prior distributions (Gamma(1,0.026; 0.05,0.026; 1,
0.001),and results were similar. County-level data was used instead of census tract-level
data since each geographic area must include at least 1 case and 1 control.
Neighborhood variables were Z-score transformed (subtracting the mean and dividing by
the standard deviation) in order to compare odds ratios from many regressions[9]. The
proportion of residual variability that is spatial in nature was calculated by dividing the
posterior marginal variance of the spatial random effects by the sum of the posterior
marginal variances of the spatial and non-spatial random effects. In this phase, there is
again a large multiple testing problem and so we adjust our significance threshold and
set it to 0.05/n for n the number of variables identified in Phase 1, which corresponds to
a Bonferroni corrected threshold of 0.05. Since we are performing a Bayesian analysis,
p-values are not available to assess significance. Hence, we calculate (100-0.05/n)%
credible intervals and neighborhood variables whose credible intervals included zero
were not considered significant. Phase 2 analyses were conducted using Integrated
Nested Laplace Approximations (INLA) [46] implemented in the INLA package in R
statistical software.
In Phase 3, we account for correlation among the most significant variables identified
in Phase 2 by applying standard principal components analysis (PCA), a technique
frequently used in neighborhood research[47, 48]. PCA converts a set of observations
of possibly correlated variables into a set of values of linearly uncorrelated variables
called principal components[47]. PCA analyzes total variance[49], and variable loadings
onto components represent the correlation between the variable and that
component[50]. PCA, as opposed to factor analysis, was chosen for data reduction in
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this study because we sought an empirical summary of total neighborhood-level
variance explained by the census variables, rather than confirmation of an underlying
factor structure comprised of previously identified domains[48, 51]. No independent
components emerged following exploratory factor analysis. We hypothesized that
variables within each principal component were correlated; this is analogous to linkage
disequilibrium in GWAS where single nucleotide polymorphisms within larger gene
regions are considered correlated[9]. Additionally, we determined that the most
significant variable within each component(i.e. the variable with the tightest credible
interval from Phase 2) was the best representation of that principal component for use in
future neighborhood and prostate cancer aggressiveness studies. This approach is
similar to fine mapping approaches that are often used post-GWAS[52, 53]. Fine
mapping methods identify the specific SNP within a gene region that is most relevant to
the outcome of interest.
In this analysis, neighborhood variables with a maximum loading of <0.30 on any of
the retained principal components were eliminated, given that loadings between 0.3 and
0.5 are considered acceptable[48] [49, 54]. Principal components (and the variables that
load on those components) that accounted for up to 90% of the data were retained in
order to determine “top hits” in this study. For variables that loaded strongly(>0.30) on
more than one component or factor variable, the magnitude of the correlation coefficient
for each component, as well as the variable description, were used to determine the
most appropriate component placement. Phase 3 was conducted using STATA/SE 12.0
statistical software.
Results
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Figure 1a displays the distribution of all prostate cancer study participants in this
analysis by census tract, and Figure1b displays the distribution of aggressive prostate
cancer cases by

Figure 1a. All Prostate Cancer Cases by Census Tract
b. Aggressive Prostate Cancer Cases by Census Tract

census tract. Of the
reported 3,135 census

A.

tracts in the
Commonwealth of
B.

Pennsylvania (PA) in
Year 2000, 3,037
(97%) census tracts

are represented in our study sample (Figure 1a; Appendix D). Most aggressive prostate
cancer cases are clustered in urban areas, namely Pittsburgh and Philadelphia (Figure
1b). The average age of the study population was 69.2 (standard deviation (sd) 9.4) and
mean year of diagnosis was 2000. The average age of aggressive cases was 69.8 (sd10.4) and of nonaggressive cases was 68.8 (sd-9.0). Figure 2 summarizes the study
methods and findings of Phases 1-3. In Phase 1, we identified 517 census variables
that were significantly associated with prostate cancer aggressiveness at Bonferroni
significance levels (Supplementary Digital File 5). In Phase 2 we identified 217 variables
that were still significant at Bonferroni-adjusted credible intervals after adjustment for
spatial variability (Supplementary Digital File 6). The average amount of spatial variation
across the 217 models was 0.34 (range: 0.14-0.50), which is considered substantial. In
Phase 3, 17 uncorrelated principal components were identified from 217 neighborhood
variables, with 76 variables loading on Component 1 and 51 loading on Component 2.
Components 1-8 explain 80% of the variance among the top 217 neighborhood
variables, and these components relate to poverty level (Component 1), white only
characteristics (Component 2), household income and worth (Component 3), male
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householders living alone component 4), rented houses built before 1939 (Component
5), civilian population (Component 6), household income above $60K (component 7),
and immigration (Component 8) (Figure 2).

The top 17 most significant variables within each of the 17 principal components are
described in Table 1. The top hit or most significant variable in this analysis (based on
significance from Phase 2) loaded on Component 12 (Workers mode of transportation).
Specifically, percent workers 16 years and over taking trolley or street car public
transportation to work was related to an OR of 1.05 and a credible interval(CI) of 1.0011.09, which can be interpreted as the odds of having aggressive prostate cancer for
each unit increase in the neighborhood percentage of workers 16 years and over taking

Figure 2. Summary of NWAS Methods and Top Neighborhood Components

Caucasian Prostate Cancer Cases

Top Neighborhood Components

Aggressive (n=6,416);
NonAggressive(n=70,670)

(by ranking of variance explained)*

#
Variables
Loading

1.Poverty (below poverty)

76

2.White Only Family and Housing

51

3.Householder income/worth

31

Phase 1: GEE Model1

4.Male Householder Living Alone

11

•Bonferroni Adjustment

5.Rented Household built 1939 or
earlier

14

6. Civilian Population

4

7. Household income >$60K

4

8.Immigration

1

9. Owner occupied housing unit worth

3

10.Poverty Status Males under 50

5

11.Housing units built 1940-49

3

12. Workers Mode of Transportation

3

14,663 Census Variables

517 variables
2

Phase 2: Spatial Model

•Bonferroni-like Adjustment

217
variables
Phase 3: Data Reduction

13.Rented Household no vehicle

4

• Principal Components Analysis

14.Males in Protective Services

1

15. Male earnings 7.5K-9,999

2

• Fine Mapping

3

16. Male over 65 (not family household) 3

Top 17 variables (Table 1)
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17. Male household renter aged 55-64

1

trolley or streetcar public transport to work. Seventeen of the top 30 variables (top 10%
of significant variables from Phase 2) loaded on Component 1(Supplementary Digital
File 6). Component 1 related to poverty and is best described by variables related to
poverty status based on income and female head of households with children variables
(Supplementary Digital File 6). The most significant variable from Component 1
represented Non-Hispanic Whites aged 6-11 for whom poverty status was determined
(OR=1.07, credible interval=1.01-1.12). In general, 15 of the top hits were
socioeconomic variables and two also related to physical environment (% Aggregate
income of Occupied Housing units built 1940-1949 and % Renter occupied housing unit
built 1939 or earlier with householder aged 15-24 years).
Discussion
Based on GWAS and EWAS frameworks, we propose the neighborhood-wide
association study (NWAS). We systematically and comprehensively assessed the
association of 14, 663 neighborhood variables measured in the U.S. Census SF1 and
SF3 forms with prostate cancer aggressiveness, based on case data from the PA State
Cancer Registry. Through a series of progressively more stringent model adjustments
and data reduction techniques, we identified the top 17 neighborhood variables
associated with aggressive prostate cancer. These findings confirm previous
associations between neighborhood and prostate cancer, and they provide new insights
into the role of neighborhood in prostate cancer development.
Previous neighborhood studies have focused on associations between prostate
cancer and pre-determined variables from the U.S. Census that represent
socioeconomic status (SES) domains related to education, income, poverty, and
employment (Supplementary Discussion Table 1-[21, 22] [23, 24] [24, 32-35] [25-27]).
Housing variables related to vacancy and median home/rental values have also been
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used as potential indicators of neighborhood SES (Appendix G). Our findings support
that neighborhood income and poverty (Components 1,2,3,7,8, 9, 10, 15), employment
(Component 14)) and housing variables(Components 3, 4, 5, 9, 11, 13, 16, 17) are
related to prostate cancer aggressiveness; however, neighborhood educational level did
not appear to be an important determinant of aggressive prostate cancer in this NWAS.
Immigration status (Component 9) has also been studied at the neighborhood and
individual-level in prostate cancer. Studies of neighborhoods with higher rates of
foreign-born immigrants have shown associations with decreased risk for cancer,
despite the socioeconomic status of the individual[55]. Even if individuals are diagnosed
with late stage prostate cancer, survival is particularly improved for those who live in
high ethnically homogeneous enclaves, suggesting the strong role that social support
may play in prostate cancer progression[55, 56]. Other variable components identified in
the NWAS have been implicated in neighborhood research or cancer research in
general, namely, variables related to mode of transportation(Components 12 and 13)
and age of housing units(Components 5, 11). Not having a vehicle or taking public
transport to work are measures that are often associated with urban vs rural areas, and
they have beenused as measures for access to medical care[57] [58, 59]. Access to
care is often cited as cause of disparity in prostate cancer treatment[58] and survival[57]
in both urban and rural settings. Higher cancer incidence and mortality rates are often
noted in more urban settings, and cases arising from rural environments often are
diagnosed at a later stage of disease[60]. Further, previous studies of neighborhood and
disease suggest that physical environment (e.g., housing vacancy) is relevant to disease
risk[30]. Age of housing unit was associated with aggressive prostate cancer in the
NWAS. Assuming that older age of the house is associated with deterioration, this
finding supports the hypothesis that poor housing can lead to poor health outcomes[61].
Thus, NWAS findings are biologically plausible, given results support the association
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between previously defined socioeconomic domains that were based on existing social
theories[62, 63].
While the NWAS top hits represent similar socioeconomic domains/components
presented in literature, the variables presented here, within each of the principal
components, are potentially more informative for inferring causation and identifying
areas in need of intervention. A limitation of previous neighborhood studies has been a
lack of consistency in variable selection for analysis[63]. For example, poverty can be
defined as the proportion of individuals or households below the federal poverty level, or
as a percentage on public assistance[48]. This lack of “common methods” or “common
neighborhood variables” for analysis is pervasive across neighborhood research in
general[48, 63], making the accumulated evidence of the role of neighborhood in
disease difficult to assess systematically for causation[63]. NWAS identified mostly
combination variables or variables that represent more than one socioeconomic
construct(e.g percentage of male householders not living with family, which represents
gender, family, household, and poverty information). Previous studies generally select a
single variable that represents fewer socioeconomic parameters (e.g. household income
only) and/or develop indices from these variables [24, 32-35] [25-27]. Improper variable
selection using a priori approaches could bias association results and lead to false
negative associations. Thus, NWAS addresses this research gap by empirically
identifying neighborhood factors relevant to prostate cancer. Additionally, it is unlikely
that previous studies would select to study both variables: percentage of male nonfamily
householders living alone AND percentage of male nonfamily householders living alone
over 65. Although these two variables appear to represent similar information by name,
the NWAS identified these variables as two separate components. Variables related to
single resident households have been used as markers of social support[64], and it is
possible that they represent separate or potentially dynamic changes in the role of social
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support across the lifespan. This is similar to findings in GWAS where top hits from the
same region may provide additional information about the function of that genetic
locus[65]. Additionally, renter versus owner-occupied housing units appeared to be
more strongly associated with aggressive prostate cancer in the NWAS, and could be
another indicator of degree of socioeconomic status, beyond income. Given the
specificity of top variables from NWAS, groups (in neighborhoods that possess these
particular neighborhood characteristics) who are likely to have unfavorable
outcomes/aggressive disease can be identified for recruitment in studies and can lead to
studies that better characterize the neighborhood environment. This could result in the
development of targeted interventions and strategies for addressing these
neighborhood-specific factors in high risk areas.
Given that this analysis was restricted to white men with prostate cancer (median age
66), it is not surprising that top hits included variables related to older age
ranges(Components 2, 10, 13, 17) and white only neighborhood characteristics
(Component 2). Neighborhood investigations often adjust by percent Hispanic or
percent African American as a measure of neighborhood segregation (24, 33-35), but
segregation or socioeconomic circumstances related to other racial groups did not
appear to be associated with aggressive prostate cancer. This could suggest that
relevant, race-specific neighborhood characteristics may predict in a manner that is
dependent on the individual subject’s own race. The conduct of an NWAS in other racial
groups is warranted in order to allow for comparisons across other race/ethnicities.
Thus, the NWAS approach has implications for health disparities research, particularly
teasing apart racial versus socioeconomic effects.
Some of the top variables did not relate to socioeconomic or physical environmental
variables, and instead related to population denominators used to calculate percentages
in the U.S. Census (i.e., Component 6) or included age ranges that are not typically
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associated with cancer development(i.e. Components 1, 5). For example, civilian noninstitutionalized population 5 years and older is an imputed variable in the SF3 form that
could reflect adjustments for study sampling approaches, given SF3 is based only on a
subset, i.e., 5% of the population. Although we made inferences using extremely
conservative significance levels, it also is possible that some of these findings could be
spurious. In the same token, there is potential for false negatives in this analysis, given
that our goal was to minimize Type I error and focus on finding true positives using a
multi-phase approach and stringent parameters for statistical significance. Further, 9 of
the top 17 variables had mean percent values of less than 1%. Although these variables
may be rare, they would still be useful for data reduction purposes, particularly if the goal
is to identify census tracts at the upper range of these particular variables for prevention
or intervention. Further, some variables, namely taking trolley or street cars to work or
living in older, rented housing units, may be a reflection of urban versus rural nature of
the U.S. Census data. More prostate cancer cases come from more densely populated
urban environments[60], but to address this issue, we account for the spatial nature of
the data in Phase 2. Although odds ratio did not change more than 8% when comparing
odds ratios from Phase 1 to Phase 2, spatial variance was substantial in our models
(greater than 30%), suggesting that spatial events should be considered in
neighborhood and cancer studies.
In general, standardized data processing and design approaches often used in
administrative datasets like the PA Cancer Registry and U.S. Census, can introduce
systematic bias and limit inferences that can be made[30]. For instance, we did not
have the ability to adjust for individual level factors beyond race, age, and date of
diagnosis. Neighborhood socioeconomic factors are believed to exert separate effects
from individual level data[21-24, 38], but conduct of NWAS in populations that allow for
individual-level adjustments will be needed in future studies, particularly to make
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generalizations about causality[22]. Bias related to data missingness is also a concern
in administrative datasets, and could be a factor in this NWAS. The response rate for
the census data for the State of Pennsylvania is 70%[66]. Also, we limited our dataset to
variables with less than 10% missingness based on GWAS, EWAS, and social
epidemiologic studies that have used an acceptable missingness level of <10%[9] [67,
68]. Based on our assessments of missingness in this study, bias related to reporting or
administrative rules appears likely nondifferential ( Appendix D); however, future studies
that investigate missingness effects in NWAS, using both spatial autocorrelation and
imputation techniques[69], are warranted.
There are other study strengths and limitations to note. A hallmark of GWAS studies
has been replication of findings in similar study populations. However, with the generally
low observed odds ratios in current GWAS studies and that fact that replication in similar
study population is not always feasible, many investigators are favoring a single
discovery phase adjusted for multiple comparisons[70]. This school of thought applies
when using State Cancer Registry and U.S. Census data. Neighborhood characteristics,
as well as disease rates, likely differ by State, thus, it’s not clear whether other State
registries would serve as appropriate replication groups. Clinical populations of prostate
cancer cases that give rise to cases within State cancer registries (that also likely include
more detailed collections of individual-level factors) and the comparison of cancer
registries within the same State from different time periods (i.e. using prostate cancer
diagnosed from 1995-2005 and the 2000 US Census versus prostate cancer cases
diagnosed from 2005-2015 and the 2010 Census) could potentially serve as appropriate
replication groups and warrant further investigation. Focus on appropriate replication
groups was outside the scope of this study, and instead we aimed to introduce the
NWAS as a nascent, but novel approach focused on discovering potentially new
research angles in neighborhood and cancer research.
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The use of county and census tract-level data does not come without some
criticism[22]. Area-level data analysis assumes that people within the same geographic
area experience similar socioeconomic circumstances. In reality, this may not be the
case and people may not spend the majority of their time at their self-reported residential
addresses. However, use of U.S. Census variables are warranted given that they are
widely available, allowing for systematic analysis and consistency across studies.
Additionally, previous studies of prostate cancer have inconsistently accounted for the
effects of spatial autocorrelation related to U.S. Census administrative boundaries[63],
and have focused mostly on socioeconomic, compared to physical environment [22, 63].
This was the first study to comprehensively evaluate the role of all available US census
variables, accounting for similarities across administrative census boundaries and
including physical and social characteristics, in cancer. We found that spatial variance
contributes substantially to model variance (though magnitudes of effect do not change
by more than 8% from Phase 1 to Phase 2). Thus, NWAS does contribute new findings
to the literature and could provide justification for more precise measurements of
neighborhood-level attributes[71]. Additionally, NWAS methodology could be applied to
other available, community or national-level databases, which could lead to more
relevant neighborhood boundary definitions.
Our prostate cancer outcome was derived from simplified and broader categories of
tumor stage and Gleason grade often employed in SEER and State Cancer
Registries[41]. Most prostate cancer cases die with and not of the disease, making
aggressive prostate cancer the most relevant outcome[20, 72, 73]. It is possible that
including more detailed clinical information related to stage, grade, metastasis, and
prostate specific antigen(PSA) level[74-76] could improve our outcome definition and the
specificity of our findings[77, 78].
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Despite limitations, this study will be the first to systematically and empirically
evaluate the role of the macro-environment in prostate cancer. We demonstrate for the
first time that high dimensional data analysis can be applied to publically available, social
datasets. Findings from this study can be used as “neighborhood signatures” in the
identification of neighborhoods that possess “high risk” characteristics and are in need of
disease intervention and prevention efforts. NWAS results are hypothesis-generating
and can lead to studies focused on the etiologic role of neighborhood on prostate cancer
and other diseases. The NWAS method has implications for health disparities research
and can be applied across a number of health and disease settings. NWAS can serve
as a common methodology across disciplines, and thus can facilitate multicenter,
multilevel investigations.

Table 1. Summary of Neighborhood Variable “Top Hits” Associated with Aggressive Prostate
Cancer by Phase Results.
Phase 1

Census Variable
%White alone
population for whom
poverty status is
determined age 611 years

Mean
(sd)

Range

Odds
Ratio

0.38
(0.53)

0-20.6

1.09

4.4
(4.7)

0-100

1.6
(1.9)

CI

Phase 2

p-value

R
a
n
k

Odds
Ratio

1.051.12

0.03

4
6
3

1.01

1.011.02

.003

0-35.4

1.03

1.021.04

4.69
(3.9)

0-39.5

1.02

0.75
(1.4)

0-31.8

1.05

Phase
3
Component
Load

CI

R
a
n
k

1.07

1.011.12

1
2

1

1
4
7

1.06

1.021.12

1
1

2

0.03

4
6
1

1.06

1.011.11

1
4

3

1.011.02

0.03

4
6
6

1.07

1.011.12

6
1

4

1.031.06

0.003

1
3
6

1.07

1.021.11

2

5

(pct_sf3_pct075a006)

%White, Nonhispanics where
poverty status
determined aged
18-64 below poverty
level in 1999
(pct_SF3_p159i007)
% Male Nonfamily
households below
poverty level
(pct_sf3_p092021)
%Male householder
living alone
(nonfamily
household)
(pct_SF3_h019093)
% Renter occupied
housing unit built
1939 or earlier with
householder aged
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15-24 years
(pct_SF3_hct00508
3)
Imputed civilian noninstitutionalized
population 5 years
and older
(pct_sf3_p120002)
%Household income
$60K-74,999
(pct_SF3_p052012)
%Foreign born
naturalized citizen at
or above poverty
level
(pct_SF3_pct05102
0)
%Household income
of $10K-19,999 with
owner-occupied
housing unit value of
$10K-19,999
(pct_SF3_hct01701
9)
% Population for
whom poverty status
is determined aged
45-54 years, under
0.50(pct_sf3_pct050
102)
% Aggregate
income of Occupied
Housing units built
1940-1949
(pct_sf3_hct015042)
%Workers 16 years
and over taking
public
transportation,
namely trolley or
street cars, to work
(pct_SF3_p030007)
Renter occupied
housing unit with
householder aged
55-64 with no
vehicle available
(pct_SF3_h045025)
%Male Protective
Service
Occupations: fire
fighting, prevention,
and law
enforcement
workers
(pct_SF3_p050026)
%Males with
earnings of $75009,999 in 1999
(pct_SF3_p084006)
Male householder
over 65 living alone
in nonfamily
household
(pct_SF1_p030012)
% Household
Renters aged 55-64
years
(pct_sf3_hct004093)

6.39
(2.6)

0-63.2

1.02

1.011.03

0.02

4
1
5

1.06

1.011.11

9
1

6

10.9
(3.6)

0-25.1

0.98

(0.970.99)

0.048

0.95

0.890.99

0-18.9

0.96

0.940.97

8.8 X
10-6

0.93

0.870.99

2
0
2
2
1
7

7

2.0
(2.1)

5
1
6
1
0

0.34
(1.1)

0-23.0

1.06

1.041.08

2.7 X
10-5

1
5

1.05

1.001.10

3

9

0.33
(0.41)

0-12.6

1.18

1.121.25

6X10-5

1
9

1.08

1.031.13

1
0

10

0.67
(1.1)

0-28.3

1.06

1.031.08

0.001

9
4

1.06

1.011.11

7

11

0.12
(0.64)

0-14.6

1.10

1.061.13

0.0001

2
5

1.05

1.0011.09

1

12

0.54
(0.99)

0-15.1

1.06

1.041.09

0.003

1
5
5

1.07

1.021.12

8

13

0.89
(0.93)

0-16.7

0.93

0.900.96

0.04

4
9
9

0.94

0.890.99

2
1
3

14

1.50
(0.96)

0-37.1

1.07

1.041.10

0.01

3
2
3

1.05

1.0011.10

4
1

15

7.2
(2.5)

0-34.5

1.03

1.021.04

.005

1
9
6

1.07

1.021.13

1
0
0

16

0.74
(0.75)

0-9.3

1.09

1.051.12

0.03

4
6
2

1.06

1.011.12

5
3

17
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Abstract
To address the complex nature of cancer occurrence and outcomes, approaches have been
developed to simultaneously assess the role of two or more etiological agents within hierarchical
levels including the: 1) macro-environment level (e.g., health care policy, neighborhood, or family
structure); 2) individual level (e.g., behaviors, carcinogenic exposures, socioeconomic factors and
psychological responses); 3) biological level (e.g., cellular biomarkers and inherited susceptibility
variants). Prior multilevel approaches tend to focus on social and environmental hypotheses, and
are thus limited in their ability to integrate biological factors into a multilevel framework. This
limited integration may be related to the limited translation of research findings into the clinic. We
propose a “Multi-level Biological And Social Integrative Construct” (MBASIC) to integrate macroenvironment and individual factors with biology. The goal of this framework is to help researchers
identify relationships among factors that may be involved in the multifactorial, complex nature of
cancer etiology, to aid in appropriate study design, to guide the development of statistical or
mechanistic models to study these relationships, and to position the results of these studies for
improved intervention, translation, and implementation. MBASIC allows researchers from
diverse fields to develop hypotheses of interest under a common conceptual framework, to guide
transdisciplinary collaborations, and to optimize the value of multilevel studies for clinical and
public health activities.

Motivation
Cancer is etiologically complex and its causes are multifactorial. Risk factors associated
with cancer development have been identified that represent a variety of levels of
influence on health and disease (Table 1). Macro-environment factors including health
system, neighborhood or community characteristics, have increasingly been linked to
cancer incidence and mortality [199, 200]. In addition, social determinants and
processes [14, 199, 201] have been identified as cancer risk factors, including
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socioeconomic status or self-reported race [202-205]. Environmental exposures at the
level of the individual [202] including cigarette smoking [206], radon [207], asbestos
[208], diet [209], and physical activity [210] are causally associated with some cancers.
Applied and fundamental investigations have identified a wide array of biologic factors
mechanistically involved in carcinogenesis including those of the tumor
microenvironment, metabolome, proteome, transcriptome, and genome. For example,
hundreds of novel genetic susceptibility loci have been identified through candidate and
genome-wide association studies (GWAS [144]).
Studies of factors at a single level have provided a great deal of insight into the
etiology of disease. Despite successes in identifying cancer risk factors, these
approaches are limited and at some point the information obtained from these singlelevel studies reach a saturation point, and have provided as much information as they
can. It is clear that the factors reported to date do not fully explain cancer incidence in
the general population. For example, while smoking is strongly associated with lung
cancer [211], most smokers will not be diagnosed with lung cancer, whereas some nonsmokers will [212]. While BRCA1 or BRCA2 mutation carriers have a greatly increased
lifetime risk of developing breast cancer [213], some BRCA1/2 mutation carriers are
never diagnosed with breast or ovarian cancer, even at an advanced age. GWAS have
identified a wealth of susceptibility genes, but the identification of novel genes using this
approach is unlikely to continue ad infinitum. Therefore, risk factors studied in isolation
and identified by standard approaches are unable to fully explain the complex,
multifactorial causes of cancer. For this reason, cancer research has evolved from
focusing on single factors to studies of complex relationships between social, behavioral,
molecular, and environmental factors.

87

Overview of Current Multilevel Approaches
To address the complex nature of cancer etiology, multilevel approaches have been
developed to simultaneously assess the role of two or more etiological agents within a
hierarchical or nested structure [6]. A number of conceptual frameworks have been
proposed that integrate information across levels of disease etiology, including the “web
of disease” of MacMahon and Pugh [7], the “wheel” of Mausner et al. [8], “systems
epidemiology”[9], and more recent models of multifactorial etiology [3, 4, 10-13].
Multilevel approaches are generally characterized by three main levels: 1) macroenvironment, referred to elsewhere as “eco-level” [3, 4]; 2) individual; and 3) biology
(Table 1). Each of these levels is further characterized by sub-levels (Table 1) that
define domains of variables involved in cancer etiology or outcomes. Multi-level
conceptual frameworks are based on the premise that factors affecting disease act
within and across levels to collectively affect disease. These approaches generally
hypothesized that cancer outcomes can result from the complex relationship of factors at
multiple levels in at least two ways (Table 1). First, factors at the macro-environment
and individual levels can directly affect the biological events and result in cancer.
Second, factors may confer risk in a hierarchal fashion, such that biologic-level effects
are affected by behaviors or exposures of the individual, and individual level effects are
affected by the macro-environment [15].

The relationships described above in the context of a multilevel model refer to both
statistical and biological interactions. Here, we use the term “interaction” generically to
refer to any non-additive statistical structure that can be constructed between two or
more factors. This concept includes that of effect modification, mediation[214], as well
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as biological structures that may be defined between two or more factors (e.g., epistasis
among genetic loci). The goal of Multi-level Biological And Social Integrative Construct”
(MBASIC) we propose below is not to define a specific form for interaction. A variety of
statistical methods have been developed to guide the implementation of hierarchal,
longitudinal or multilevel models [6, 215-217]. Instead, MBASIC provides a framework
around which a researcher can generate hypotheses about the relationship among
etiological agents in a consistent manner. When results of these hypothesis tests are
known, investigators using this framework may be better able to compare and combine
their results to form more coherent multilevel inferences.

Most multilevel approaches lack a detailed focus on mechanisms that can be used to
frame the relationships between macro-environment or individual- level factors. In part,
the limited incorporation of mechanistic hypotheses stems from the early multilevel
frameworks having evolved from research focused on social factors. Thus, multi-level
conceptual approaches have tended to take a “top-down” approach that is focused on
the role of social determinants at the macro-environment level (Table 2). Only more
recently has a detailed consideration of the biological level been included in multilevel
studies. For instance, the model of Warnecke et al. [10] centers on health disparities as
the outcome of interest and defines macro-environment level factors by policies,
institutions, and social or physical factors. They also include a single level including
biological factors. Similarly, the models of Taplin et al. [4] and Gorin et al. [3] focus on
improved cancer care, sub-dividing the macro-environment level by national and state
health policy, local community environment, organization or practice setting, health care
provider teams, and family/social support. Across proposed multi-level frameworks, the
traditional individual level risk factors for cancer (e.g., smoking, race, diet) are also
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considered, whereas biological factors in these constructs remain broadly defined by
genes, proteins, enzymes and other somatic changes in the cellular environment [2-4].
In these models, all biological processes are treated in a manner similar to those of other
levels without accounting for the extensive knowledge of biological processes, pathways,
and etiologic relationships that are involved in carcinogenesis.

Approaches that focus on macro-environment have had an impact on the conceptual
advancement of our understanding of disease etiology. While the National Institutes of
Health has increasingly recognized and encouraged the use of multilevel approaches to
go beyond investigating individual level factors to include macro-environment level
exposures [218, 219], many of the current approaches[218, 219]come from the
perspective of social and environmental research, and the full integration of biological
level factors has yet to be realized. A search of PubMed for the term “multilevel
analysis” or “multilevel model” and “cancer” resulted in 55 articles published between
2002 and 2012, although the majority of these (26 of 55, 47%) were published since
2010. Most of these studies focused on individual-level and macro-environmental
factors, and few incorporated biological factors. Thus, work is needed to improve the
understanding of which factors at each level are relevant to the disease, the hierarchical
nature of the relationship of those factors, and the effective application of integrative
multilevel approaches to achieve meaningful etiological inferences.

Multi-level Biological and Social Integrative Construct (MBASIC).
To the degree that a researcher has knowledge of biological mechanisms of human
cancer, multilevel models could be used to harness this information and to generate
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hypotheses that link macro-environment or individual level factors with mechanisms of
carcinogenesis. Current multi-level conceptual approaches, while created to promote
multi-disciplinary research, often lack detailed descriptions of the biological level that
could be used to unite traditionally distinct fields (e.g., molecular biology and social
epidemiology). MBASIC defines the multilevel framework (construct) to include three
main hierarchal levels that contribute to cancer etiology and levels of carcinogenesis
(i.e., macro-environment, individual, and biological factors; Figure 1), where the
biological level is more specifically defined. This multilevel etiological model is then
placed in the context of interventions, and translation/implementation (i.e., T0-T4; [220,
221]; Figure 1) Thus, this framework allows researchers from the fields of public
health, health policy, prevention, behavioral sciences, sociology, epidemiology, biology,
clinical medicine, and others to test hypotheses of interest under a common conceptual
framework, to address the dynamic nature of carcinogenesis, to facilitate translation of
multilevel studies to clinical and public health strategies, and to support multi-disciplinary
collaborations.

The primary goal of MBASIC is to consistently and systematically frame complex
hypotheses about cancer etiology, that once tested, can expeditiously inform
intervention and implementation levels, under the umbrella of a common framework. As
may be expected with any comprehensive conceptual framework, the full range of
MBASIC components is not meant to be implemented in any one study. Instead,
MBASIC is meant to aid the researcher in stating hypotheses for individual studies that
address a part of the complete framework. Thus, MBASIC provides the framework for
hypotheses that allow comparison and compilation of individual study results using
formal (e.g., meta-analytic) or ad hoc means. Individual studies built around the
91

MBASIC framework could also motivate multidisciplinary collaborations and could
rationalize single, large-scale multilevel studies in the future.

Predictive and Mechanistic Links Between and Among Hierarchical Levels of
Etiology
An important goal of the MBASIC is to guide researchers to consistently and
systematically incorporate biological mechanisms into a multilevel framework. Despite
the substantial limitations in our ability to generate meaningful statistical or
epidemiological models of mechanism and biological events [222, 223], knowledge of
existing biological pathways emerging from animal, tumor, and other in vivo studies can
be employed to improve generation of hypotheses about how each of the three
hierarchal levels relates with the others in order to frame questions about the complexity
of cancer etiology[224]. The well-known molecular epidemiology paradigm [225-229]
provides a useful structure into which existing biological knowledge can be incorporated
into a multilevel framework. As shown in Figure 2 and defined below, the effect of
exposures can be measured by biomarkers of biologically effective doses (BED), early
biological effects (EBE), and altered structure and function (ASF) that are predictive of
disease [226-229]. The formation of these biomarkers can be influenced by inherited
genotypes (IG). These factors can give rise to somatic genomic (SG) changes involved
in carcinogenesis. Note that while prior constructs include markers of internal dose,
which have great value as biomarkers for research, clinical or screening purposes, we
exclude these in the present framework to emphasize biological and mechanistic effects
in the multilevel etiology of cancer. While spontaneous mutation may give rise to the
biomarkers of disease and effect shown in Figure 2, the multilevel construct assumes
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that each of the biomarkers occur in response to an initial macro-environment or
individual level exposure, even though that exposure may not be known or measurable.

We adapt the traditional molecular epidemiology approach [226-229] in two ways: by
considering the nested hierarchical nature of the multilevel model (Figure 2); and by
expanding the definition of “exposure” to include both macro-environment level and
individual level exposures. As noted in Table 1, relevant etiological factors can be
measured by biomarkers (i.e., BED, EBE, ASF) of exposure or disease at the biological
level. These biomarkers reflect somatic changes and are often measured at the tissue
or cellular level. For example, biomarkers of exposure to cigarette smoking at the
individual level can be measured by exposure biomarkers such as DNA adducts [226229] in blood; prostate specific antigen (PSA) levels or chromosomal instability [229]
measured in blood can serve as markers of disease. Thus, these factors may be framed
as both processes leading to disease and as intermediates reflecting the relationship
between macro-environmental and individual factors, separately, and disease (Table 1).
For instance, macro-environment level variables can induce a psychological response,
which can be directly measured at the biological level. Witnessing a crime in a
neighborhood environment can lead to flight or fight cellular responses that cause
increases in cortisol levels. Thus, cortisol is a biomarker of a macro-environment
exposure. An example of a linkage between the individual level and the biological level
is that of the human exposome [230]. The exposome is defined by environmental
exposures (including lifestyle factors) that represent combined exposures from all
sources, from the prenatal period onwards [230]. The exposome can be measured by
biomarkers at the cellular level via bodily fluids or tissue that can serve as surrogates for
exogenous or endogenous environmental exposures. For instance, exposure to
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organophosphate pesticides can be measured by certain metabolites, and dietary
factors, like vitamin intake, can be measured by antioxidant metabolites. Like the GWAS
approach, epidemiology has employed environment-wide association studies (EWAS)
[230, 231] that use an agnostic approach to identifying environmental factors involved in
disease. Future EWAS studies in cancer are warranted to provide practical evidence for
a link between individual level exposures and the biological level. While EWAS and
GWAS share some conceptual similarities, there are numerous methodological
differences between the two approaches[232]. However, the results of each can provide
information that may promote the development of multilevel hypotheses in cancer
etiology.

While the examples above demonstrate how macro-environment and the individual level
factors can each separately affect the biological level as an exposure, we can also
demonstrate the hierarchal effect among exposures at multiple levels on the biologic
level. For example, exposure to a group of friends who smoke cigarettes could prompt
an individual to change her behavior and also start to smoke cigarettes. This change in
behavior at the individual level influences molecular carcinogenesis at the biologic level
(i.e. DNA adducts; BED) and chromosomal damage (ASF). Despite symptoms of
decreased lung function over the course of 15-20 years, the individual is genetically
predisposed to nicotine dependence, is unable to quit smoking, and ultimately ends up
developing lung cancer. Here, the behavior change served as an intermediate between
the macro-environment and biological events involved in carcinogenesis. Thus, this
example demonstrates the biological plausibility of how a macro-environmental factor
can impact an individual, affecting her biological environment, ultimately resulting in
disease. When the macro-environment, individual, and biological factors are collectively
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considered in order to predict or explain a cancer outcome, statistical methods will be
needed to determine which levels or which risk factors within each level are most
relevant to the cancer outcome under study. Thus, it is possible for intermediates to
serve as surrogates of exposure and disease, but the importance of each level and each
factor within each level will need to be determined statistically based on available
methods.

Biology in a Multilevel Framework
Starting with the Levels of Etiology (Figure 1), the biological level can be subdivided into
sub-levels with a hierarchical order based on our knowledge of biology and
carcinogenesis: tissues are comprised of cells, which contain genes. Somatic
mutations and cellular events (e.g. DNA replication) may be involved in carcinogenesis.
In the following sections, we build the framework around which the biological level can
be optimally incorporated into multilevel analysis (Figure 2).

Tissues: Tissues warrant consideration as a unique biological sub-level in a
multilevel framework for two reasons. First, cellular markers and processes that are
measured in normal tissue, pre-neoplasia, or malignant tumors could serve as potential
markers of exposure, disease, or prognosis. Second, tumors occur at the tissue level.
Most cancers are diagnosed and staged using tissue samples or by imaging techniques
that may identify lesions in a particular organ. A growing area of research is focused on
the tumor microenvironment, defined by normal cells, signaling molecules, matrices and
blood vessels that surround and feed a tumor cell [233]. A tumor can alter its
microenvironment (as defined by cellular and genomic sub-level factors), and the
95

microenvironment can affect how a tumor grows and spreads. Data about the role of the
tumor microenvironment are rapidly becoming available via initiatives such as The
Cancer Genome Atlas (TCGA; http://cancergenome.nih.gov).

Cells: The cellular sub-level is characterized by proteins, enzymes, and other
biomarkers that can be detected in bodily fluids and tissues. In the context of our model,
the cellular level includes the transcriptome, proteome, and metabolome, where
biomarkers of exposure and disease can be measured (Figure 2). The transcriptome
includes the various forms of RNA in the cell that affect gene expression and cellular
function [234-236]. The proteome includes the total set of proteins expressed in a given
cell at a given time [235]. Examples of factors measured in the proteome include
prostate specific antigen (PSA) and CA-125 [229, 234, 237]. Complex protein
interactions are referred to as the metabolome [235, 238]. Therefore, even within the
cellular sub-level, there is an emerging hierarchy [235]. Many approaches for disease
biomarker discovery focus on a single biomarker at the cellular level, despite an
emerging expectation that panels of biomarker analytes will be needed to provide
sufficient sensitivity and specificity for cancer screening, diagnosis or prognosis [234,
238]. Therefore, there is a shifting focus to the role of the pathway-based and statistical
interactions among cellular factors, but progress in this area is limited by available, highthroughput technologies that can detect and organize the millions of proteins obtained
from a given biological sample.

Somatic Genomics (SG): The SG sub-level (Figures 1 and 2) is defined by acquired
somatic genomic changes over the course of a person’s lifetime. The SG level is
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defined by factors that can be both markers of disease and markers of exposure. SG
examples include mutations, copy number variants, and epigenetic changes occurring in
DNA [234, 239]. Early studies of SG used methods that identify potential susceptibly loci
a priori, but this approach used a small number of genetic markers, rarely identified
robust associations between candidate genes and cancer, and most findings were not
replicable in other studies [144].

Inherited Genomics (IG): The IG sub-level (Figures 1 and 2) is comprised of inherited
susceptibility loci that serve as markers of disease risk and outcome. IG includes
hereditary cancer syndromes [240], which confer a high risk of cancer development. IG
research may use family-based linkage methods to identify important inherited, highpenetrance genes, such as BRCA1 and BRCA2. However, the mutations in these
genes are rare in the general population [144, 201, 213], and only explain a small
fraction of familial aggregation and cancer risk. GWAS have identified many dozens of
cancer susceptibility loci [227, 241], most of which were not previously hypothesized to
be involved in cancer susceptibility [144]. Despite this success, genetic risk variants
identified from GWAS, alone and in combination, explain a relatively minor proportion of
disease risk, and have had limited translational value to the clinic. This has led to a
focus on the identification of rare variants that may account for larger proportions of
cancer genetic risk[145].

Given the limited clinical utility of SG and IG findings focused on single disease loci and
statistical interactions thereof, there has been a renewed interest in studying epistasis,
defined as genes at two or more loci that produce phenotype effects that are different
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than the expected effects of the individual loci [242]. At both the SG and IG sub-levels,
gene-gene interaction studies are being conducted to ascertain the independent and
joint effects of risk loci on cancer outcomes [243]. These studies may use multiple
cancer risk susceptibility loci based on pathway or shared biological function, or be
combined using statistical predictive models independent of biological knowledge.

Non-Hierarchical Effects Within and Across Levels of Etiology
Mechanisms and example methodologies have been proposed to build on the definition
of the biological level and to illustrate how interactions between and among factors at
each level relates to one another, assuming a hierarchal structure for levels of etiology
(Figure 1). Hypotheses that consider the hierarchical framework of MBASIC are readily
constructed from the discussion provided above. However, the effects of factors within
each of these levels need not follow a strict hierarchy. In the context of predictive (as
opposed to mechanistic) models, each level can dynamically affect another. Thus,
statistical (causal) inferences need not be constrained in a linear hierarchical fashion
[244]. Concepts in social science and genetics support this assertion. According to the
Social Ecological Perspective [245, 246], human health results from the complex
interaction of personal factors (e.g., behaviors, biology, psychology) as well as physical
and social environments (e.g., geography, built environment, culture, economics,
politics, and social relationships) [245]. For instance, a combination of geography,
psychology, and behavior without a clear hierarchal or biological link could interact
(statistically) and affect disease outcomes. Additionally, changes in eating habits at the
individual level may affect social relationships at the macro-environment level since a
person who is more conscious of their eating habits may prefer to be around other
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healthy eaters; the effect of each level on the other is not necessarily linear, top-down, or
bottom-up. In the field of genetics, penetrance [247] is defined by the probability of a
phenotype given genotype. Even though a person is born with a disease genotype, lack
of exposure to harmful environmental factors or carcinogens may prevent the disease
from occurring. While it is likely that the disease genotype and exposure have some
biological link, in the absence of this knowledge, specific methodologies aimed at
analyzing gene-environment interactions, more recently, gene-environment interactionwide association studies (GEIWAS) [248], can be developed to help elucidate statistical
interactions across levels. Since it is clear that biological, social, and environmental
factors interact in some way in cancer etiology, a multilevel framework is needed to both
organize and guide traditionally separate fields of cancer research; however, these
frameworks should also account for the dynamic nature of the disease.

Expanding MBASIC: Levels of Intervention, Implementation and Evaluation
MBASIC expands the utility of the multilevel approach by including levels of etiology and
carcinogenesis with levels of intervention and implementation/evaluation, all of which
can influence one another in a nonlinear manner. Levels of intervention are
characterized by primary, secondary, and tertiary prevention strategies and survivorship
that range from risk assessment to detection to diagnosis and treatment (Figure 1).
Previous multilevel studies have focused on assessing factors within the levels of
intervention [14], particularly cancer care outcomes like detection or screening at the
individual level or practice setting sub-level [3, 4].
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The implementation/evaluation level is characterized by changes made through the
application and translation of relevant interventions [249]. Implementation/evaluation
may occur through national, state, or local policy or health care systems changes, and
the impact of interventions and implementation will ultimately be seen in changes to the
health status of a population. The levels of implementation/evaluation are based on the
translational model of Khoury et al. [220, 221], which describes five translational phases
(Figure 1): T0/T1 (determination of mechanisms, etiology and development of
interventional strategies); T2 (development of evidence-based policy and practice); T3
(implementing evidence-based guidelines to elicit health care system changes); and T4
(surveillance and monitoring the effect of changes on health outcomes in populations).
Appropriate consideration of the dissemination, implementation, and evaluation of
research findings into health systems is critical if the potential of multilevel models is to
be realized. For instance, knowledge of the role of macro-environmental factors (e.g.,
residential location, social environment) in individuals with specific biological
characteristics and risk factor profile could provide a resource-efficient approach to early
detection or screening for cancer.

Simultaneous consideration of multiple levels in the MBASIC framework may impact a
number of cancer outcomes. The levels or sublevels of inference (etiology,
carcinogenesis, intervention, or implementation/evaluation; Figure 1) could serve as the
outcome or exposure of interest. For instance, healthcare system changes (e.g.,
insurance coverage) can affect individual level behavior (e.g., participation in smoking
cessation programs), which can affect the cellular environment (e.g., carcinogen levels
and formation of DNA adducts). Therefore, interactions within and across levels can be
modeled in a variety of ways, and extent to which the four levels of inference impact the
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trait of interest will vary depending on the etiological setting. For instance, during cancer
initiation, living in a community that promotes cancer screening and having access to
primary care may play a prominent role in cancer early detection(ref). After cancer is
diagnosed, the oncology provider and social support may become a predominant
influence on clinical and psychosocial outcomes. Both of these scenarios may be
imposed on a common biological context (e.g., a cancer having a specific mechanistic
cause), but the relevant individual and macro-level factors may differ substantially.

MBASIC Example: Prostate Cancer
In the United States, prostate cancer (CaP) is the second leading cause of cancer death
in men [250]. CaP is of public health concern because it disproportionately affects
different races. African American men are more likely to be diagnosed with and die from
CaP than any other racial group, and this disparity is the largest observed for any cancer
[251]. Despite the burden of CaP, particularly for African American men, little is known
about the etiology and predictors of poor prognosis for the disease. At present, the only
widely agreed-upon risk factors for CaP are at the individual level: race, age, and family
history of CaP [153]. Tumor and patient characteristics used to identify men with a poor
prognosis include tumor stage, Gleason score or grade, and prostate-specific antigen
(PSA) level at diagnosis. However, these clinical characteristics are imperfect in their
ability to determine long-term prognosis and appropriate treatment options. Thus, CaP is
a good example of the potential value of the MBASIC framework.

PSA Screening: From the Cellular Level to T4 Implementation
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In the 1980s, studies on the cellular level demonstrated that PSA levels could serve as
markers for CaP recurrence [252]. The use of PSA screening for patients undergoing
treatment was approved in 1986 [252-254]. Despite studies in the late 1980s suggesting
that PSA might not be an ideal biomarker for screening and early detection of CaP [252254], the FDA also approved PSA as an early detection screening test in 1994, and PSA
became one of the first FDA approved early detection biomarkers for cancer [252]. The
FDA based its approval on a large clinic study whose results suggested that men with
PSA values above 4.0mg/mL could be biopsied for cancer[255]. As a result of this
bench to beside clinical translation (T1 phase), screening guidelines with often
conflicting recommendations from different organizations like the United States
Preventive Services Task Force [256], the American Cancer Society [257], and the
National Comprehensive Cancer Network [258], started to emerge. These guidelines
affected clinical practice (T2 phase), resulting in more men being screened for and
diagnosed with CaP [252]. The health care system was also affected by these
guidelines: insurance companies, particularly the Veterans Association and Medicare,
incurred large costs covering routine PSA screening (T3 phase) [259]. Continued
research at both the population level (T4 phase) and levels of causation (cellular and
individual levels) in more recent years have shown that PSA screening may not improve
CaP mortality rates, that early detection of CaP can often lead to unnecessary treatment
for some and insufficient treatment in others [252, 260, 261]. As a result, researchers
continue to developed enhanced PSA screening tests that are more sensitive and
specific [252]. Guidelines for routine PSA screening are continually being revised in the
context of individual level factors. These include questioning the utility of screening for
men under the age of 75 [256], focusing on screening high risk groups [202], and
recommending baseline PSA measures in men under age 50 [145]. Despite its
limitations and controversies, PSA screening illustrates how cellular and individual levels
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of causation, resulting biomarker interventions, and health care implementation (Figure
1) can inform one another to optimize the early detection of CaP.

The PSA scenario also suggests that a comprehensive evaluation of PSA in early
detection of CaP may benefit from the use of MBASIC to frame the hypotheses and
approaches needed to improve screening and treatment for CaP. While macro-level
factors have yet to be widely used in the context of PSA screening, it is not hard to
imagine that screening strategies may be optimized by having a better understanding of
those men who are most likely to have unfavorable CaP outcomes based on their socioeconomic situation, access to health care, or other macro-environmental factors. The
role of macro-environmental factors in CaP risk and mortality are beginning to emerge
from the health disparity and PSA screening literature. Screening behaviors can be
affected by economic, physical, and social characteristics of residential neighborhoods
[262]. Neighborhoods considered to be disadvantaged or low-income have been
correlated with higher levels of pollutants, overcrowding, violence, less social cohesion,
and less access to services [263].[263]. Screening practices can affect CaP incidence,
and low-income neighborhoods often have fewer medical facilities that are overburdened
with indigent care to provide optimal screening[262]. This can lead to differential
screening practices by neighborhood [264] and differences in both the diagnosis and
treatment of CaP, particularly among Caucasian versus African American men [151,
265]. Therefore, neighborhood measures could serve as a surrogate for access to care
in CaP, and appear to be a relevant macro-environment level measure to investigate for
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this cancer outcome. In the setting of an MBASIC approach, men with known biological
risk profiles may therefore benefit from targeted intervention if they also reside in defined
disadvantaged neighborhoods. For instance, this concept is further illustrated by a
multilevel analysis that investigated the role of individual level characteristics and
census-tract neighborhood variables and stage of prostate cancer. Consistent with data
showing an association between race, stage, and socioeconomic circumstances like
living in a low income area, using geographical information systems technology, Xiao et
al. [266] went beyond identifying factors associated with prostate cancer stage and
suggest community education and outreach in areas with unfavorable neighborhood
characteristics. In the context of MBASIC, discovery and early translation can be
leveraged in a single study and can provide additional insights that would not be as
readily apparent in studies focusing on a single etiological level.

Prostate Cancer Disparities: Piecing Together Studies on Biology and Neighborhood
Because of the complex etiology of CaP, an understanding of CaP disparities may
benefit from a multilevel approach. A growing body of literature supports this
hypothesis. Rundle et al. [267] reported an association between neighborhood SES
(based on median income level of a census tract) modifies the association between
individual smoking status and PAH-DNA adduct levels in prostate tissue (BED). We
reported an interaction between CaP genetic susceptibility loci identified in GWAS and
census-tract level neighborhood variables on time to PSA failure in men who had
undergone radical prostatectomy [32]. We identified no main effects of the genetic
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variants or neighborhood factors on PSA failure by themselves, but found statistically
significant interactions between neighborhood variables and the susceptibility loci.
Specifically, genotypes at MSMB and HNF1B/TCF2 predicted time to PSA failure in men
from disadvantaged neighborhoods. This suggests that context-specific effects of
genotype should be explored and may improve the ability to identify groups that may
experience poor CaP outcomes. It is important to note that these studies represent
predictive models that may have implications for implementation or translation, but
themselves do not provide direct mechanistic conclusions. In general, these studies
may motivate a continued focus on multi-level approaches and provide rationale for the
utility of multilevel models in cancers like CaP, where typical single disciplinary
approaches provide limited insight into disease etiology.

Charge to the Scientific Community

We have proposed a unifying conceptual framework that allows researchers from public
health, policy, oncology, health services research, behavioral science, epidemiology,
and the biomedical sciences to test hypotheses of interest under a common framework.
The MBASIC framework allows researchers to generate common inferences from
otherwise disparate individual research findings by using a common conceptual model.
As illustrated by the prostate cancer example, taking a multilevel approach can help to
expedite translation of etiologic findings into translational efforts, more than would occur
in studies focused on single levels of etiology alone. By providing a stronger basis for
inclusion of biological factors in a multilevel hierarchy, MBASIC bridges the gap between
social science and biology in order to foster multidisciplinary collaboration and
streamline intervention, implementation, and translation efforts. Emerging biomedical
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technologies enable population-based studies to include biomarker data such that the
landscape of cancer research is changing and the lines between disciplines are
increasingly blurring. MBASIC can serve as a road map for hypothesis generation and
the development of emerging multidisciplinary teams. The MBASIC framework allows
individual studies to more effectively piece together individual research findings under a
common conceptual model. Knowledge gained from this integration can be used to
rationalize the costs of future, large-scale, multilevel studies. Finally, MBASIC
represents a framework around which transdisciplinary research (i.e., research that
generates new fields of inquiry) can be built.
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Table 1: Hierarchical Level Definitions
Level

Factors at this Level Can
Serve As:

Sub-Level

Macro• Health Policy (National, State,
Environment
Local)
• Community, Neighborhood
• Social and Built Environment

• Exposures that affect individual
risk factors
• Exposures that affect biological
processes
• Contextual variables [32]

• Practice Setting and Health
Care Providers
• Family and Social Support
Individual

• Behaviors

• Exposures leading to disease

• Exposures

• Intermediates between the
macro-environment and
disease

• Psychological Determinants
• Socioeconomic Factors
Biological

• Tissue

• Processes leading to disease

• Cell

• Intermediates and biomarkers
reflecting the relationship
between macro-environmental
and individual factors

• Somatic Genome (SG)
• Inherited Genome (IG)
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Table 2: Multilevel Framework Examples
Level

Hiatt and Breen
[14]

MacroEnvironment

Defined by
Factors:
Social
determinants
and Health
Care Systems

Individual

Defined by
Factors: Social
Determinants,
Behavioral/
Psychological
factors

Biologic

Defined by
Factors: genes
and biomarkers

Primary
Outcome
of Interest

Cancer Control
Continuum
(Pre-disease,
pre-clinical,
incidence,
morbidity/

Warnecke et al.
[10]
Defined by sublevels (from
largest to
smallest): Social
conditions (e.g.,
discrimination),
Institutions (e.g.,
Families),
Neighbor-hood,
Social
Relationships
Defined by
Factors: Age,
Socioeconomic
status,
Education,
Obesity,
Tobacco Use,
Acculturation,
Diet, Race

Defined by
Factors:
Allostatic Load
(e.g.,
combination of
stress markers
or other
biomarkers),
Metabolic
Processes,
Genetic
Mechanisms
Cancer Health
Disparities
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Taplin et al. [4]
Gorin et al. [3]

Morrissey et
al. [26]

Defined by sublevels:
National/state
policy, local
community,
organization or
practice setting,
health care
providers, family/
social support

Defined by
sub-levels
from Taplin
et al. [4]
Gorin et al.
[3]

Defined by
Factors:
Biological
Factors,
Sociodemograph
ics, insurance
coverage, risk
status,
comorbidities,
knowledge,
attitudes, beliefs,
decision-making
preferences,
psychological
reaction/coping

Similar to
Taplin et al.
[4] Gorin et
al. [3] where
individual is
described as
the patient.

Defined by
sub-levels
(largest to
smallest
level):
Organ,
Tissue, Cell,
Gene,
Molecule,
Atom
Cancer Care
Continuum
(Risk
assessment,
primary
prevention,

Cancer Care
Continuum

survival,
mortality)
Interventions
(Prevention,
early detection,
diagnosis/treatment, quality of
life)

detection,
diagnosis,
treatment,
survivorship, end
of life)
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Figure Legends
Figure 1: Multi-level Biological And Social Integrative Construct (MBASIC). This
framework includes levels of etiology, carcinogenesis, intervention, and
implementation/evaluation, as well as previously defined phases of translation (i.e., T0T4; [220, 221]. Biological levels include inherited genome (IG), somatic genome (SG),
as well as related biomarkers of biologically effective dose (BED), biomarkers of early
biological effect (EBE), and biomarkers of altered structure and function (ASF) [225].

Figure 1
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Macro-Environment
Individual
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Survivorship

Biological

Initiation
Promotion

Levels of
Intervention
1o, 2o, 3o Prevention

Levels of
Carcinogenesis

Figure 2: Incorporating Molecular Epidemiology and Biomarkers in the Multilevel
Framework.
Biological levels include inherited genome (IG), somatic genome (SG), as well as related
biomarkers of biologically effective dose (BED), biomarkers of early biological effect
(EBE), and biomarkers of altered structure and function (ASF) [225].
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APPENDIX B
Overview of Systematic Review of Multilevel Studies in Cancer Etiologic Research

I.

II.

III.

IV.

Background. A number of multilevel conceptual models exist in cancer research(see
Lynch and Rebbeck, CEBP, 2013). In general, these models state that macroenvironment, defined by neighborhood, families, hospitals; individual factors, like
behaviors, exposures and social circumstances; and biologic factors, like genes and
other molecular markers, can each individually and/or collectively affect cancer
outcomes.
Problem/hypothesis. A number of these conceptual models exist, but they have not
been tested in literature. Very few cancer studies include factors from all 3 levels:
macro-environment, individual and biology, or consider macro-environment and
biology together, when studying cancer outcomes.
Study Aims. The goal is to conduct a systematic review to identify the number of
cancer studies that include factors from all 3 levels (or at least the macro and biologic
levels) and summarize their findings in order to begin to identify research gaps,
evaluate the utility of multilevel conceptual frameworks, and suggest next steps.
Study Methods. A manuscript review was conducted to identify multilevel cancer
epidemiology research studies. A multilevel study is defined here as a study that
includes the analysis of an association between a cancer outcome and variables at
ALL three hierarchal levels, macro-, individual, and biologic levels OR at least the
macro- and biologic levels in adult populations. Cancer outcomes could include,
incidence, prevalence, mortality, case-control status, or prognosis outcomes.
Biologic outcomes could include biomarkers related to oxidative stress, given these
markers have been implicated in cancer at the biologic level. Otherwise, articles
were excluded if only one or two levels (namely individual and macro-level or
individual and biologic level) were represented in the analysis. Gene-environment
interaction studies where the environment was measured at the individual level were
excluded since they only represented one level outside the individual. An advanced
search of the electronic database, PubMed/Medline, was conducted between MayJuly 2014. Studies from 2002 to the present were identified by entering required
terms: “cancer” and “epidemiology”, with alternating key words focused on identifying
macro-environmental studies including: family relations (n=63), health disparities
(n=276), macroenvironment (n=3), multilevel (n=268), neighborhood (n=284) then
combining the following biologic level terms with selected macro-environmental terms
listed above, “genotype” and “macroenvironment”( n=1), “biomarker” and
“neighborhood” (n=0), and : “gene environment interaction” (n=245). Key words were
also paired individually with the terms “biomarker” and “genes” including: “family
practice” and “genes” (n=6) and “family practice” and “biomarker” (n=0), “health
services” and “genes” (n=27) and “health services” and “biomarker” (n=11),
“healthcare disparities” and “genes” (n=1) and healthcare disparities” and “biomarker”
(n=1), “poverty” “gene” (n=3) and “poverty” “biomarkers” (n=23), “psychology” and
“genes” (n=87) and “psychology” and “biomarker” (n=8), “social perception” and
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V.

“genes” (n=1) and “social perception” and “biomarker” (n=0), “social support” and
“genes” (n=6) and “social support” and “biomarker” (n=1), “socioeconomic factors”
and “genes” (n=31) and “socioeconomic factors” and “biomarker” (n=10), and “state
medicine” and “genes” (n=0) and “state medicine” and “biomarker” (n=0). Citations in
articles were cross-referenced to obtain additional sources.
Results: Studies that met inclusion criteria are summarized in Table 1, and include
descriptions of methodological approaches, cancer/biomarker outcomes, and study
findings. One study includedfactors at all 3 levels and 4 studies included
investigations of macro-environment or neighborhood on biomarkers indicated in
cancer.

Appendix B Table 1. Evaluation and Summary of Multilevel Cancer Studies from 2002-Present
Study Characteristics
Sample
Study
Race/
Size
Design
Gender

Studies
by
author,
year
Rebbeck
et al,
2010[32]

Barrington

et al,
2014[33]

Cohort
Survival
Analysis

Crosssectional

444

543

White
males

White
men
and
women

Outcome

Prostate
cancer
biochemical
failure
(BF)

Cortisol
reactivity

Multi-Level
Macroenviron
mental
Predictor
/confounders

Approaches
Individual
Level
Factor(s)
Predictors
/confounders

Predictors:
U.S.
Census
Tract
variables:
Aging/
social
isolation;
education
;Housing
quality;
SES:

Confounder:
Age

Predictors:
Neighbor
hood
Deprivation

Predictors:
Age,
gender,
work,
education,
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Method
Biologic
Factors/
confounders

Statistics

Findings

Confounder:
Tumor
Stage/
Gleason
Grade

Cox
models

Significant
association
found
between BF
and MSMB
and older
single
heads of
households
and HNF1B
and
income.

Multilevel
Growth
Curve
Model

Significant
relationship
between
Neighborhood
Deprivation

Predictors:
3p12,
multiple
regions at
8q24,
11q13,
17q24;
and
candidate
genes
including
CTBP2 ,
HNF1B/T
CF2,
JAZF1,
LMTK2,
MSMB,
and
NUDT ,
Xp11,
KLK3,
OATP1B1
RNASEL,
MSR1

Index

Waggaman

et al,
2014[35]

Epplein
et al
2012[34]

Needham et
al.,
2014[31]

Crosssectional

Cohort

Crosssectional

669

665

973

Black,
Hispanic,
White
women

Precancer
cervical
lesions

336
Black
men
and
woman;
329
White
men
and
women

Seronegativity
to H.
pylori
and
CagA

Hispanic,

Telomere
Length

Black,
White
men
and
women

Predictors:
Proportion
female
black or
Hispanic
or living
below
poverty at
census
tract level
Predictors:
US
Census
2000
used to
find
income or
wealth;
education
; work
;crowding
Social
environment and
Neighbor
hood Disadvantage

fear of
crime,
social
control
Confounders:
Age, race

Confounders:
Race
(African
American
ancestry)
and Marital
status.

Confounders:
Age, race,
lifestyle
factors,
biomedical
factors,
socioeconomic
factors

and Cortisol
Level in
women

Poisson
Model

Polytomous
logistic
regression

Linear
Multilevel
Models

Found a a
marginally
significant
interaction
(P < 0.05)
between
individual
race/
ethnicity
and area
race
Neighborhood-level
measures
of
education,
work and
house
values are
associated
with CagA+
H. pylori
seroprevalence
Neighborhood social
environment

was
associated
with
Telomere
Length
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APPENDIX C
Systematic Review of Multilevel studies in Telomere Length.
A manuscript review was conducted to identify epidemiologic, multicenter studies
focused on factors affecting telomere length in adult populations. A multicenter study is
defined here as a study comprised of individual research projects that collected data
independently, then collaborated with other projects, and merged data to analyze
telomere length as an overall, combined study outcome. Articles were excluded if only
one university or academic center oversaw and was responsible for original data
collection under a single study protocol, or if the main association analysis remained
stratified by project or center. This is because the methodological concerns associated
with varying population characteristics and laboratory methods are often minimized
under these circumstances, and these studies have been reviewed previously [17, 52,
53, 58] (See supplementary methods).
A search of the electronic database, PubMed/Medline, was conducted in 2014.
Studies from 2002 to the present were identified using the key words, “telomere length”
paired with “multicenter(n=16)” or “consortium(n=12)” or “registry”(n=12). Citations in
articles were cross-referenced to obtain additional sources. Study design, type of risk
factor, or disease under study were not selection factors since the focus of this
investigation is on methodological considerations in multicenter studies, not overall
association findings. Eleven articles were retrieved and 9 met the criteria for inclusion
listed below:
1. Research studies that involved adult, human participants and combined data
from multiple centers with a primary aim of assessing the relationship between a
risk factor and telomere length measured in blood.
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2. The study reported clear methodologies for measuring telomere length.
3. It was written in English.
We summarized methodological approaches for each study based on laboratory,
population factors, and statistical approaches known to affect telomere length
measurements in literature[17, 52, 53, 58, 73] (Supplementary Table 1).

Supplementary Table 1. Evaluation and Summary of Methodologies employed in Multicenter,Telomere Length(TL) Association Studies from 2002-Present
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Interassay:
2.724.8%

2
4
7
1
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Mean TL
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logtransfor
med T/S
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Z-Score
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y age
and sex
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(Mean TL
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Salting
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q-PCR
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TRF
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2
2
.
7
6
9
.
3

White
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Heart,
no
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No
report

Mean TL
(bp from
T/S ratio
vs TRF
plots
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(Mean TL
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6.80-9.82)

Phenol/
Chloroform;
Qiagenb

q-PCR

No
report

5
2
6
2

White

0

No
disease

No
report

Mean TL
from
Cycle
adjustments
and
base
pair
calculati
ons from
the T/S
ratio)

Yes. TL
adjust by
plate and
TL as a
CT
outcome.
No center
difference

Puregene;
Phenol/
Chloroform;
Qiagenb

5

Blood
Leukocyte

Puregen
e;
Phenol/
Chlorofo
rm;
Qiagenb

1

Blood
Leukocyte

2

Blood
Leukocyte

(21
EuropeCoh
orts)

Mau-baret
et al. 2013

Intraassay:
1.52%
Interassay:
3.53.9%

Blood
Leukocyte

(5
Europecoh
orts)

Codd et al.
April 2013

q-PCR
(n=4)c /
TRF(n=
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5

(5
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e-control
studies)

Bojesen et
al. 2013
(Combined
3
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cohorts)

c
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2. Metaanalysis
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regressi
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study. 2.
Meta-

Findings
vary by
study in
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TERT loci
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w/ longer
TL
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8 and
rs770552
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8
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PCR

1
9
9
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Heart
disease
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and
negative
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age in
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and
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not by
sex

Mean TL
age and
bmi
adjust;
Difference in
mean TL
by race
and
gender

Not
reported

4
4
.
5
6
0
.
5

White

52

Cancer
and
heart
disease

Significant
and
Negative

Logtransformed
T/S ratio
adjust
for age,
sex, and
center

No center
effet after
adjust for
age.

(2
EuropeCoh
orts)

Levy et al.
2010
(Combined
4 US
Cohorts
and 1
European
Twin Study)

Hunt et al.
2008

1

(2 U.S.
studies,
one family
and one
pop-ulationbased)

Nord-fjall et
al. 2008
(2
EuropeCoh
orts)

analysis

1

(international
biobank,
registry,
and
SPORE
studies)

Weis-her et
al., 2012

and
relative
change
in mean
TL per
minor
allele.
T/S ratio
or logtransformed
T/S ratio
and differences
in ratios
bt DNA
extraction

Blood
Leukocyte
; T-cells
and
neutrophil

CV:
1.43%
CV:
2.40%

White/
Blackf

qPCR:
6.40%

1

Blood
Leukocyte

Qiagen,
phenolchloroform,
Puregene,
Chemag
enb

q-PCR

CV:
3.96%
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Quartile
of TL
base
pairs
(derived
from
Cycle
(CT) )
adjustments
and
base
pair
calculations
from the
T/S
ratio).
Mean TL
(bp)

Yes,
based on
DNA extraction

ANCOV
A

Yes. Lab
difference
assumeba
sed on
adjustment by
plate
Center
difference no
report

Chisquare,
Kruskal
Wallis,
p-trend
treating
TL as
an
ordinal
variable.

No report

Metaanalysis
using
Linear
Regress
ion and
linear
mixed
effects
regressi
on
(family
studies)
adjusted
for age,
age2,
sex,
bmi,
smoking
.
Generali
ze
estimati
ng
equatio
ns and
exchangeable
correlati
on
matrix
compari
ng racespecific
associat
ion of
age with
TL
adjusted
for
sex/BMI
Analysis
of
covarian
ce and
correlati
on

RTL
measured
by
Qiagen
extracted
DNA is
smaller
than other
methods
which
could
influence
inconsistency
across
studies
TL
associate
w/ age,
bmi, male
gender,
smoking,
alcohol
intake.

TERC
and
OBFC1
associate
d with TL;
Findings
not
reported
by study.

Sex- and
BMIadjusted
TL
became
shorter
with age
at a
steeper
slope in
blacks
than in
whites;
Findings
not
reported
by study.

TL
associate
with an
“obesityphenotyp
e” but
only in
women

a

Quantitative Polymerase Chain Reaction(q-PCR) is often reported as a ratio of telomere length
repeat length (T) to copy number of a single-copy gene or standard(S) DNA, called a T/S ratio;
Southern blot assays report telomere length in terms of base pairs(bp).
b
Had to consult source manuscripts to identify potential sources of DNA extraction and did not
find this information for each cohort in some instances. Also, for some cohorts, DNA extraction
methods were different in two separate source manuscripts and it’s unclear which extraction
method was used for the telomere length study.
c
Different DNA standards(S) were used to generate T/S ratios and were used to explain
differences in mean T/S ratios across studies or cohorts.
e
In the genome-wide association study(GWAS), all were white participants(n=3417).
f
In the replication of the GWAS findings(n=1893), the study population included whites and
blacks and findings differed slightly by race, which could have been due to the small sample size
of blacks(n=574).

Supplementary Laboratory Methods
Terminal Restriction Fragment (TRF) assay: Genomic DNA samples were digested
with restriction enzymes Hinf I (10 U) and Rsa I (10 U; Roche), then the digested DNA
samples (1-5 µg each) along with molecular weight DNA markers (1-kb DNA ladder plus
λ DNA/Hind III fragments; Invitrogen, Carlsbad, CA) were resolved on 0.8% agarose
gels and transferred to nitrocellulose membranes by southern blotting. Membranes were
hybridized overnight using radioactively-labeled (TTAGGG) probes, and the radioactive
signal was detected and digitized using a phosphorImaging system. The
phosphorImager signals (adjusted for background) versus DNA migration distances
were determined for each sample[91], and mean TRF in kb was determined using
Telorun software[91]. Each sample was run in duplicates on separate gels, and the
average value in kb was used.
The overall telomere lengths for each

Quantitative Telomere PCR (qPCR):

experimental sample are determined relative to the reference DNA by comparing the
difference in their ratios of the telomere copy number (T) to the single copy gene copy
number (S) using quantitative PCR. This ratio has been found to be proportional to
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average telomere length2. The qPCR reactions are set up as 10ul reactions in a 384 well
plate compatible with the Applied Biosystems, 7900 HT. The final DNA concentration for
each experimental sample is approximately 20ng diluted in 5 ul of water. Each plate also
contains a set of standards (using the reference DNA) spanning an 81-fold range
prepared by serial dilution and analyzed in triplicate1. These reactions generate the
standard curves used for relative quantitation. The multiplex qPCR assay from Cawthon1
was modified to make it compatible with the ABI 7900 HT. Two master mixes of PCR
reagents were prepared, one with the telomere primers (telc and telg) and the other with
either the albumin pair (albd, and albu) or the beta-globin pair (hgbu, and hgbd). LTL did
not vary by reference gene primer. Five micro-liters of each master mix was added into
the appropriate wells. The final concentrations in each PCR reaction were 0.8X SYBR
Green I Master Mix (Agilent Technologies), and 900nM of the telomere pair, or 900nM of
the albumin pair, or 500nM of the beta-globin pair.
The thermal cycling profile used was 15min at 95°C, 2 cycles of 15s at 94°C, 15s at
49°C, followed by 32 cycles of 15s at 94°C, 10s at 62°C, and 15s at 74°C with data
acquisition. The plates were read at 74°C to minimize the interference from the telomere
primer-dimers. The ABI software SDS version 2.0 was used to generate two standard
curves from each plate, one for the telomere amplification, and the other for the single
copy gene. The ratio (T/S) of the telomere copy number (T) to the single gene copy
number (S) was generated for each experimental sample, and the value was averaged
across the triplicates. The T/S ratios relative to the reference sample were generated
using the comparative CT(cycle threshold) method. Center samples were batched
analyzed to minimize inter-assay variation.
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Supplementary Table 2. Unadjusted Median and Mean LogTelomere Length(TL)by
Study Characteristics(No Cancer, n=1261)
Median TL (kb)
(Interquartile Range)a
Age
Younger age(<=51)
Older age(>51)
Gender
Female
Male
Race
Non-Hispanic White
African American
Hispanic
Education
> High School
High School/GED
<High School
Perceived Stress
High Stress
Low Stress
Depression
High Depression
Low Depression

6.35(4.33-8.17)
6.16(4.26-8.17)

p-valueb

Mean
logTL(SD)

p-valuec

0.52

1.78(0.44)
1.76(0.46)

0.49

0.12

1.78(0.44)
1.74(0.46)

0.13

0.03

1.73(0.44)
1.77(0.48)
1.79(0.45)

0.08

0.13

1.75(0.45)
1.74(0.47)
1.81(0.42)

0.07

6.16(4.23-8.17)
6.38(4.37-8.15)

0.29

1.76(0.45)
1.78(0.45)

0.72

6.45(4.50-8.44)
6.26(4.26-8.03)

0.20

1.79(0.44)
1.75(0.45)

0.22

6.33 (4.48-8.27)
6.01 (4.10-8.00)
5.96(4.24-7.92)
6.48(4.37-8.32)
6.44 (4.42-8.32)
6.18(4.21-8.06)
6.05(4.18-8.19)
6.44(4.59-8.16)

Medians(interquartile range for the median); b p-values comparing characteristics across 3 or
more groups using Kruskal Wallis Test, otherwise used Wilcoxon Ranked Sum Test; c p-values
comparing characteristics across 3 or more groups using ANOVA, otherwise used T-test.
a

REFERENCES:
1. Cawthon, R.M (2009). Telomere length measurement by novel monochrome
multiplex quantitative PCR method. Nucleic Acids Res., 37, e21
2. Cawthon, R.M (2002). Telomere measurement by quantitative PCR. Nucleic
Acids Res., 30, e47

141

APPENDIX D

NWAS Supplementary Material
Phase 0. Data Cleaning
I.

Characterization of Data Missingness by Outcome and Neighborhood
Variables

Prostate Cancer Outcome. Overall, there were 93,308 incident cases of prostate cancer
between 1995-2005 in the State of Pennsylvania. We focused this analysis on Caucasians
only (prostate cancer cases=80,575). 112 prostate cancer cases were dropped because
their home address was a non-descript P.O. Box address, 6 more were dropped because
of missing age and date of diagnosis, leaving 80,457 cases. The main outcome variable,
prostate cancer aggressiveness, is a combination variable comprised of tumor stage and
grade data. The stage variable is never missing, and the grade variable is missing for
3,371 prostate cancer patients(4.2% of total cases). Thus, we had 77, 086 Caucasian
cases left for an analysis with our primary outcome variable; 6, 416 were classified as
aggressive cancer and 70,670 cases were classified as “non-aggressive.”
Neighborhood variables. Selection of Year 2000 U.S. Census variables for inclusion in
this analysis from SF1 and SF3 is summarized in Appendices E and F, respectively. We
assessed percent missingness for each census or neighborhood variable from the 2000 US
Census SF1(n=8113) and SF3 forms(n=15,521) for just the variables from the US Census
and after the join that linked the cancer registry to the US census data. Percentage
available are reported in SF1 Supplementary Digital File 1(variables included in analysis)
and Digital File 2(variables excluded from analysis), columns B(census file availability)
and C(join file availability), and SF3 Supplementary Digital File 3(variables included in
analysis) and 3(variables excluded from analysis), and columns B(census file availability)
and C(join file availability). Columns B and C correspond to the percentage of census
tracts reporting a value(either a percentage, mean, or median) for each census variable,
which equates to percent non-missingness for that variable. SF1 and SF3 Supplementary
Digital file 1 and 3, respectively, show which variables were included in the final NWAS
analysis (SF1 n=5,943; SF3 n=10,599), based on having less than 10% missing data; SF1
and SF3 Digital Files 2 and 4, respectively, show which variables had missingness
greater than 10% and were excluded from the analysis. Using SF1 Supplementary
Digital File 1 as an example, for each census variable, %nonmissingness in column C
was slightly higher than %nonmissingness in column B, but the difference(Column D)
was generally not more than 3-6.5%. Thus, census or neighborhood variable missingness
did not appear to be majorly affected by the incorporation of case status after joining the
2000 U.S. Census data SF1 and SF3 forms to the Pennsylvania State Prostate Cancer
Registry (1995-2005).
Census Tract Level. Individual prostate cancer cases were linked to Year 2000 Census
SF1 and SF3 forms at the census tract level. Of the reported 3, 135 census tracts in the
entire State of Pennsylvania in Year 2000, 3,037 census tracts are represented in our
Caucasian population. Thus, 97% of PA census tracts are covered in this analysis. On
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average, there were 2 cases of aggressive prostate cancer compared to 23 controls with
non-aggressive prostate cancer in each census tract. We also assessed case status by
census block group, but there were <1 cases on average and 8 controls in each census
block group. Prostate cancer grade missingness did not appear systematic by census tract
(in the grade variable, 3,033 census were represented). Thus, missingness is likely at
random.
Statistical Analysis. Using the joined (combined registry and census) final dataset, 1346
(SF1=748; SF3=598) neighborhood variables(8% of the final analytic set) would have
been excluded based on census only missingness (missingness>10% in column B in
Appendix A for both SF1 and SF3), but were included in the analysis because
missingness improved to <10% after the join(column B). After running Phase 1, only 1
of these variables were included in the top 517 hits, and none of these variables were in
the top hits after Phase 2, thus findings did not change by this inclusion criteria.
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APPENDIX E
Year 2000 SF1 Variable Missingness Descriptions for the State of Pennsylvania
Year 2000 SF1 Variables Pulled from Social Explorer(http://www.socialexplorer.com)
Year 2000 SF1 Variables Linked to Pennsylvania State Prostate Cancer Registry 1995-2005
Census Tract Level

Key: Percentage Variables take the Census base variables from which it originates and
divides percentage variables by base variables. Social Explorer calculates these variables.
Master Variables often serve as denominator variables, such as Total Number of Households.
In some cases, it is relevant to include in statistical models, therefore, all master variables with
appropriate levels of missingness (i.e. less than 10%) are included in the statistical models
(n=286) Some Census Base variables were not represented as percentages, but are relevant
because they report means or medians, thus, are included in the analysis (n=43)
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APPENDIX F

Year 2000 SF3 Variable Missingness Descriptions for the State of Pennsylvania
Year 2000 SF3 Variables Pulled from Social Explorer(http://www.socialexplorer.com)
Year 2000 SF3 Variables Linked to Pennsylvania State Prostate Cancer Registry 19952005

Key: Percentage Variables take the Census base variables from each census table and
divide it by the appropriate master variable from the table with which it originates.
Social Explorer calculates these variables. Master Variables often serve as denominator
variables, such as Total Number of Households. In some cases, it is relevant to include
in statistical models, therefore, all master variables with appropriate levels of
missingness (i.e. less than 10%) are included in the statistical models
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APPENDIX G
Supplementary Discussion Table 1. Examples of Neighborhood Methods used in
Prostate Cancer Research

Study
(data source)

Neighborhood
variables

Outcome

Results

Ref

Method: Neighborhood Indices
Hellenthal et
al. 2010 (CA
Cancer
Registry)

Principal
components
analysis used to
create an SES
score(1-5, 5 being
the highest),
including median
household
income, education
level, proportion
below 200%
poverty,

PCa
Men of lower SES
Treatment/Survival are less likely to
undergo radical
prostatectomy (RP)
or radiation (XRT) for
the management of
localized prostate
cancer. After RP or
XRT, men of lower
SES have a
decreased cancerspecific survival
compared with men
of higher SES.

and median house
value.
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[39]

ZeiglerJohnson et al.
2011 (PA
Cancer
Registry)

1. Analyzed
individual SES
variables from
Census. 2.
Calculated a
deprivation index (1 to 1, with 1 being
the highest
deprivation index)
using a principle
components
analysis (PCA),
including:

Prostate cancer

The highest quartile
[40]
of neighborhood
deprivation was also
associated with high
Gleason score. For
both Caucasians and
African-Americans,
the highest quartile of
neighborhood
deprivation was
associated with high
Gleason score at
diagnosis (OR=1.27,
95% CI=1.11-1.44;
OR=1.61, 95%
CI=1.15-2.25,
respectively.) Using
a neighborhood
deprivation index,
associations between
prostate cancer
severity and
neighborhood
deprivation across
ethnic groups was
observed.

Prostate Cancer
risk and mortality

Higher levels of SES
were associated with
lower mortality rates
of prostate cancer
deaths (SES Q1 vs.
Q5: RR = 0.88; 95%
CI: 0.92–0.94).
African-Americans
had a twofold to
fivefold increased
risk of prostate
cancer deaths in
comparison to nonHispanic Whites
across all levels of
SES.

(1) % of households
with income
<$30,000/year
(2) % poverty;
(3) % households
on public
assistance
(4) % female head
of household with
dependent children
(5) % households
with no car.
Cheng et al.
2009
(CA Study)

Principal
component analysis
to develop single
SES index from
seven censusbased indicator
variables of SES:
1. mean years of
education; 2.
median household
income; 3. percent
living 200% below
poverty level;
4.percent bluecollar workers; 5.
percent older than
16 years in
workforce without
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[41]

job;
6. median rent;
7. median house
value . This index
was used to assign
a standardized
score to each
census block group,
which was then
categorized into
quintile levels.
Lyratzopoulous
et al. 2010
(United
Kingdom)

The United
Kingdom 2004
Indices of
Deprivation.

Prostate Cancer
After a diagnosis of
Treatment/Survival prostate cancer, men
from lower
socioeconomic
groups were
substantially less
likely to be treated
with radical surgery
or radiotherapy. The
causes and impact
on survival of such
differences remain
uncertain.

[38]

Byers et al.
2008 (NPCR
POC Study)

Both education and
income were
classified into 2
Levels (<25% vs
25% of adults aged
25 years with less
than a high school
education and
<20% vs 20% of
households with
incomes below the
Federal Poverty
Level). Each
patient was then
classified as living
in a census tract
with neither low
education nor low
income (65% of
cases), with only 1
of those indicators

Advanced
Prostate, Breast,
colon cancer

[36]
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Low SES was
associated with more
advanced disease
stage and with less
aggressive treatment
for all 3 cancers.

of low SES (20% of
cases), or with both
of those indicators
(15% of cases).
Schymura et
al. 2010
(CDC-NPCR
PoC1)

Records were
linked by census
tract. The following
variables were
analyzed
individually:

Prostate Cancer
survival

1. poverty (<20%
versus 20%+ of
residents below the
2000 poverty level);

No neighborhood
variables were
associated with
survival from
localized prostate
cancer

[42]

State of residence
was a significant
predictor of treatment
type and overall
survival.

2. education (<25%
versus 25%+ of
residents age
twenty-five and
over with less than
a high school
education);
3.working class
status (<66%
versus 66%+
working class
occupations);
4. urban-rural
residence (totally
urban, totally rural,
urban-rural mix, or
unknown).
Marlow et al.
2010 (national
cancer
database)

Socioeconomic
status was
classified using the
median household
income and
proportion of
population with a
high school diploma
from patient's ZIP
code of residence.

Advanced
Prostate Cancer
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Patients residing in
areas with lower
socioeconomic
characteristics have
significantly
increased odds of
advanced PCa.

[43]

